fastsette hva som er narkotika forebygge spredning og misbruk av narkotika, herunder sikre forsvarlige kontrolltiltak sikre tilgang til nødvendige legemidler til medisinsk og vitenskapelig bruk.
Forskrift om narkotika (narkotikaforskriften)
Ansvarlig departement: Helse- og omsorgsdepartementet
| Stoffnavn | Internasjonal regulering | Forbudt etter § 5 | Unntak og spesielle bestemmelser | CAS-nummer |
|---|---|---|---|---|
| 1-(3-Klorfenyl)-piperazin (mCPP) | Forbudt etter § 5 | 6640-24-0 | ||
| 1,4-Butandiol | 110-63-4 | |||
| 1-Benzylpiperazin (BZP) | P II | Forbudt etter § 5 | 2759-28-6 | |
| 1-Fenyl-2-(1-metyletylamino)pentan-1-on (N-isopropylpentedron) | Forbudt etter § 5 | 18296-65-6 | ||
| 2-(4-Metylpiperazin-1-yl)-1-fenylpropan-1-on | Forbudt etter § 5 | 93865-44-2 | ||
| 2-(Etylamino)-1-fenylheptan-1-on; se N-etyl heptedron | – | |||
| 2-(Etylamino)propiofenon (etkatinon) | Forbudt etter § 5 | 18259-37-5 | ||
| 2-(Metylamino)-1-fenylheksan-1-on (heksedron) | Forbudt etter § 5 | 2169446-41-5 | ||
| 2,3-Dimetyletkatinon (2,3-DMEC) | Forbudt etter § 5 | 2705531-06-0 (HCl-salt) | ||
| 2,3-DMMC | Forbudt etter § 5 | 1448258-72-7 | ||
| 2,3-MDMC (2,3-metylendioksymetkatinon) | Forbudt etter § 5 | 1427205-87-5 | ||
| 2,4,5-TMMC | Forbudt etter § 5 | 1368603-85-3 | ||
| 2,4-DMMC | Forbudt etter § 5 | 1225623-63-1 | ||
| 2,4-DMPPP | Forbudt etter § 5 | – | ||
| 2,5-Dimetoksy-4-etyltioamfetamin (aleph-2) | Forbudt etter § 5 | 185562-00-9 | ||
| 2,5-Dimetoksy-4-fluoramfetamin | Forbudt etter § 5 | 125903-69-7 | ||
| 2,5-Dimetoksy-4-isopropylamfetamin (DOiP, DOiPr) | Forbudt etter § 5 | 42306-96-7 | ||
| 2,5-Dimetoksy-4-nitroamfetamin | Forbudt etter § 5 | 67460-68-8 | ||
| 2,5-Dimetoksyamfetamin (2,5-DMA) | Forbudt etter § 5 | 2801-68-5 | ||
| 2,5-DMMA (2,5-dimetoksymetamfetamin; metyl-DMA (2,5-dimetoksy-N-metylamfetamin)) | Forbudt etter § 5 | 54687-43-3 | ||
| 2,6-Dibrom-meskalin | Forbudt etter § 5 | 734477-60-2 | ||
| 25N-NBOMe (2C-N-NBOMe, NBOMe-2C-N) | Forbudt etter § 5 | 1354632-03-3 | ||
| 2-Brom-4,5-dimetoksyfenetylamin; se 4,5-dimetoksy-2-bromfenetylamin | 63375-81-5 | |||
| 2-Brom-meskalin (2-Br-M) | Forbudt etter § 5 | 37015-19-3 | ||
| 2C-B | P II | Forbudt etter § 5 | 66142-81-2 | |
| 2C-B-FLY | Forbudt etter § 5 | 733720-95-1 | ||
| 2C-B-NBOMe (NBOMe-2-C-B, 25B-NBOMe) | P I | Forbudt etter § 5 | 1026511-90-9 | |
| 2C-C | 88441-14-9 | |||
| 2C-C-NBOMe (NBOMe-2C-C, 25C-NBOMe) | P I | Forbudt etter § 5 | 1227608-02-7 | |
| 2C-D | 24333-19-5 | |||
| 2C-D-NBOMe (NBOMe-2C-D, 25D-NBOMe) | 1354632-02-2 | |||
| 2C-E | 71539-34-9 | |||
| 2-CEC | Forbudt etter § 5 | 879660-23-8 (HCl-salt) | ||
| 2C-E-NBOMe (NBOMe-2C-E, 25E-NBOMe) | Forbudt etter § 5 | 1354632-14-6 | ||
| 2C-F | Forbudt etter § 5 | 207740-15-6 | ||
| 2C-G | Forbudt etter § 5 | 207740-18-9 | ||
| 2C-G-NB-OMe (NBOMe-2C-G, 25G-NBOMe) | Forbudt etter § 5 | 1354632-65-7 | ||
| 2C-H | Forbudt etter § 5 | 3600-86-0 | ||
| 2C-H-NBOMe (NBOMe-2C-H, 25H-NBOMe) | Forbudt etter § 5 | 919797-16-3 | ||
| 2C-I | 69587-11-7 | |||
| 2C-I-NBOMe (25I-NBOMe) | P I | Forbudt etter § 5 | 919797-19-6 | |
| 2C-iP (jelena) | Forbudt etter § 5 | 1498978-47-4 | ||
| 2-Cl-4,5-MDMA | Forbudt etter § 5 | – | ||
| 2-CMC | Forbudt etter § 5 | 90869-66-2 (HCl-salt) | ||
| 2C-P | 207740-22-5 | |||
| 2C-T-2 | 207740-24-7 | |||
| 2C-T-21 (4-(2-fluoretyltio)-2,5-dimetoksyfenetylamin) | Forbudt etter § 5 | 207740-33-8 | ||
| 2C-T-4 | 207740-25-8 | |||
| 2C-T-7 | 207740-26-9 | |||
| 2-EEC | Forbudt etter § 5 | 1439439-82-3 | ||
| 2-EMC | Forbudt etter § 5 | 1863642-82-3 | ||
| 2-FA | Forbudt etter § 5 | 1716-60-5 | ||
| 2-FEA | Forbudt etter § 5 | 3871-89-4 (HCl-salt) | ||
| 2-Fluordesklorketamin | P II | Forbudt etter § 5 | 111982-50-4 | |
| 2-Fluorfentanyl (ortofluorfentanyl) | N I | Forbudt etter § 5 | 910616-29-4 | |
| 2-FMA | Forbudt etter § 5 | 1017176-48-5 | ||
| 2-FMC | Forbudt etter § 5 | 1346599-37-8 (HCl-salt) | ||
| 2-Klor-N-etylamfetamin | Forbudt etter § 5 | 1153916-07-4 | ||
| 2-MA (ortetamin) | Forbudt etter § 5 | 5580-32-5 | ||
| 2-MEC | Forbudt etter § 5 | 1439439-84-5 | ||
| 2-Me-PVP (2-metyl-α-PVP, 2'-Me-PVP) | Forbudt etter § 5 | 850352-54-4 | ||
| 2-Metylacetylfentanyl | Forbudt etter § 5 | – | ||
| 2-Metyl-AP-237 | N I | Forbudt etter § 5 | 98608-61-8 | |
| 2-Metyletylbufedron (2-metyl-N-etylbufedron, 2-metyl-α-etylaminobutiofenon) | Forbudt etter § 5 | 690616-16-1 | ||
| 2-Metylmetamfetamin | Forbudt etter § 5 | 861007-65-0 | ||
| 2-Metylmetoksyacetylfentanyl (orto-metyl metoksyacetyl fentanyl) | Forbudt etter § 5 | 2748485-23-4 (HCl-salt) | ||
| 2-Metyl-α-PiHP (2-metyl-α-PHiP, 2-metyl-α-pyrrolidinoisoheksanofenon) | Forbudt etter § 5 | – | ||
| 2-MMA | Forbudt etter § 5 | 93-30-1 | ||
| 2-MMC | Forbudt etter § 5 | 1246911-71-6 | ||
| 3,4-DCEC | Forbudt etter § 5 | 2518105-51-4 (HCl-salt) | ||
| 3,4-Diklor-N,N-sykloheksylmetylkatinon | Forbudt etter § 5 | – | ||
| 3,4-Dimetoksy-α-PHP | Forbudt etter § 5 | – | ||
| 3,4-Dimetyletkatinon (3,4-DMEC) | Forbudt etter § 5 | 1225811-81-3 | ||
| 3,4-Dimetyl-α-PVP (3',4'-dimetyl-α-pyrrolidinovalerofenon) | Forbudt etter § 5 | 2748485-15-4 (HCl-salt) | ||
| 3,4-DMA | Forbudt etter § 5 | 120-26-3 | ||
| 3,4-DMMC | 1082110-00-6 | |||
| 3,4-EDMC (bk-EDMA) | Forbudt etter § 5 | 30253-44-2 (HCl-salt) | ||
| 3',4'-MDPBP (MDPBP) | Forbudt etter § 5 | 784985-33-7 | ||
| 3',4'-MDPHP (MDPHP) | Forbudt etter § 5 | 776994-64-0 | ||
| 3,4-Metylendioksy PV8, MDPEP (MD-PV8, MDPHPP) | Forbudt etter § 5 | 746541-09-3 | ||
| 3,4-Metylendioksy-α-pyrrolidinoisoheksanofenon (3,4-metylendioksy PiHP, MDPiHP) | Forbudt etter § 5 | 749145-17-3 | ||
| 3',4'-Tetrametylen-α-pyrrolidinobutiofenon (TH-PBP) | Forbudt etter § 5 | 2749504-65-0 (HCl-salt) | ||
| 3-Allylfentanyl | Forbudt etter § 5 | 86151-80-6 | ||
| 3-BMC | Forbudt etter § 5 | 676487-42-6 (HCl-salt) | ||
| 3-CEC | Forbudt etter § 5 | 2150476-60-9 | ||
| 3-CMC (klofedron) | P II | Forbudt etter § 5 | 1049677-59-9 | |
| 3-Desoksy-MDPV; se 5-DBFPV | 2117405-32-8 | |||
| 3-EEC | Forbudt etter § 5 | – | ||
| 3-EMC | Forbudt etter § 5 | 1603134-08-2 | ||
| 3-FA | Forbudt etter § 5 | 1626-71-7 | ||
| 3-Fluoretylamfetamin (3-fluoretamfetamin, 3-FEA) | Forbudt etter § 5 | 54982-43-3 | ||
| 3-Fluorfentanyl | Forbudt etter § 5 | – | ||
| 3-Fluorisobutyrfentanyl (3-FIBF, meta-fluorisobutyrfentanyl) | Forbudt etter § 5 | – | ||
| 3-Fluormetoksyacetylfentanyl | Forbudt etter § 5 | – | ||
| 3-Fluor-α-PPP (3'-fluor-α-pyrrolidinopropiofenon) | Forbudt etter § 5 | 1214940-15-4 (HCl-salt) | ||
| 3-FMA | Forbudt etter § 5 | 1182818-14-9 | ||
| 3-FMC | Forbudt etter § 5 | 1049677-77-1 | ||
| 3F-NEB (3-fluor-N-etylbufedron, 3-fluor-α-etylaminobutiofenon) | Forbudt etter § 5 | – | ||
| 3F-NEH (3F-N-etylheksedron) | Forbudt etter § 5 | – | ||
| 3F-PHP (3-fluor-α-PHP, 3F-α-pyrrolidinoheksanofenon) | Forbudt etter § 5 | – | ||
| 3F-PiHP (3F-α-PHiP) | Forbudt etter § 5 | – | ||
| 3F-α-PVP | Forbudt etter § 5 | – | ||
| 3-Klorkatinon | Forbudt etter § 5 | 119802-69-6 | ||
| 3-Klor-N-etylamfetamin | Forbudt etter § 5 | 744983-82-2 | ||
| 3-MAM | 5140-28-3 | |||
| 3-MeA | Forbudt etter § 5 | 77083-25-1 | ||
| 3-MEC | Forbudt etter § 5 | 2493976-59-1 (HCl-salt) | ||
| 3-MeOMC | Forbudt etter § 5 | 882302-56-9 | ||
| 3-MeO-NBOMe (3-MeO-PEA-NBOMe) | Forbudt etter § 5 | 1176460-16-4 | ||
| 3'-Me-PVP (3'-Me-α-PVP, meta-pyrovaleron) | Forbudt etter § 5 | 13415-85-5 | ||
| 3-Metoksyamfetamin (3-MA; meta-metoksyamfetamin, MMA) | Forbudt etter § 5 | 17862-85-0 | ||
| 3-Metoksyfensyklidin (3-MeO-PCP) | P II | Forbudt etter § 5 | 72242-03-6 | |
| 3-Metylbutyrfentanyl (3-MBF) | Forbudt etter § 5 | 97605-09-9 | ||
| 3-Metylfentanyl | N I+IV | Forbudt etter § 5 | 42045-86-3 | |
| 3-Metylflefedron | Forbudt etter § 5 | – | ||
| 3-Metylkrotonylfentanyl | Forbudt etter § 5 | – | ||
| 3-Metyl-N-propyl-katinon (3-metyl-α -propylaminopropiofenon) | Forbudt etter § 5 | – | ||
| 3-Metyltiofentanyl | N I+IV | Forbudt etter § 5 | 86052-04-2 | |
| 3-Metyl-α-PHiP (3-metyl-α-PiHP, 3-metyl-α-pyrrolidinoisoheksanofenon) | Forbudt etter § 5 | – | ||
| 3-MMC | P II | Forbudt etter § 5 | 1246816-62-5 | |
| 4,4'-DMAR | P II | Forbudt etter § 5 | 1445569-01-6 | |
| 4,5-Dimetoksy-2-bromfenetylamin | 63375-81-5 | |||
| 4-AcO-DET | 1135424-15-5 | |||
| 4-AcO-DiPT | 936015-60-0 | |||
| 4-AcO-DMT | 92292-84-7 | |||
| 4-AcO-EPT (4-acetoksy-N-etyl-N-propyltryptamin) | Forbudt etter § 5 | 2750249-90-0 | ||
| 4-AcO-MET | Forbudt etter § 5 | 1445751-40-5 | ||
| 4-AcO-MiPT | 1024612-25-6 | |||
| 4-AcO-MPT (4-acetoksy-N-metyl-N-propyltryptamin) | Forbudt etter § 5 | 2173386-55-3 | ||
| 4-BMC | Forbudt etter § 5 | 486459-03-4 | ||
| 4-Bromfentanyl (para-bromfentanyl) | Forbudt etter § 5 | 117994-23-7 | ||
| 4Br-α-PPP | Forbudt etter § 5 | 1152859-02-3 | ||
| 4Br-α-PVP | Forbudt etter § 5 | 850352-17-9 (HCl-salt) | ||
| 4-CA | Forbudt etter § 5 | 64-12-0 | ||
| 4-CBC | Forbudt etter § 5 | – | ||
| 4C-D (ariadne, α-Et-2C-D, 4C-DOM, dimoksamin) | Forbudt etter § 5 | 52842-59-8 | ||
| 4-CEC | Forbudt etter § 5 | 14919-85-8 | ||
| 4-CIC | Forbudt etter § 5 | – | ||
| 4-Cl-3-MMC (4-klor-3-metylmetkatinon) | Forbudt etter § 5 | 15861-86-6 | ||
| 4-CMA | Forbudt etter § 5 | 30572-91-9 | ||
| 4-CMC (klefedron) | P II | Forbudt etter § 5 | 1225843-86-6 | |
| 4-EEC | Forbudt etter § 5 | 1225619-32-8 | ||
| 4-EMC; se 4-etylmetkatinon | 1225622-14-9 | |||
| 4-Etylmetkatinon | Forbudt etter § 5 | 1225622-14-9 | ||
| 4-Etyl-α-PVP | Forbudt etter § 5 | – | ||
| 4F-3-metyl-α-PHP (4-fluor-3-metyl-α-pyrrolidinoheksanophenon) | Forbudt etter § 5 | – | ||
| 4-FEC | Forbudt etter § 5 | 1225625-74-0 | ||
| 4-Fenylfentanyl | Forbudt etter § 5 | 120448-97-7 | ||
| 4-FIBF | N I | Forbudt etter § 5 | 244195-32-2 | |
| 4-Fluoramfetamin (4-FA) | P II | Forbudt etter § 5 | 459-02-9 | |
| 4-Fluorbufedron | Forbudt etter § 5 | 2624137-27-3 (HCl-salt) | ||
| 4-Fluorbutyrfentanyl (4-FBF) | N I | Forbudt etter § 5 | 244195-31-1 | |
| 4-Fluoretylamfetamin | Forbudt etter § 5 | 3823-30-1 | ||
| 4-Fluorisobutyrfentanyl; se 4-FIBF | 244195-32-2 | |||
| 4-Fluormetoksyacetylfentanyl | Forbudt etter § 5 | – | ||
| 4-Fluor-N-isopropylpentedron | Forbudt etter § 5 | – | ||
| 4-Fluorpentedron | Forbudt etter § 5 | 2131054-74-3 | ||
| 4-FMA | Forbudt etter § 5 | 351-03-1 | ||
| 4-FMC (flefedron) | 447-40-5 | |||
| 4F-MDMB-BINACA | P II | Forbudt etter § 5 | 2390036-46-9 | |
| 4F-NEB | Forbudt etter § 5 | – | ||
| 4F-NEP | Forbudt etter § 5 | – | ||
| 4F-PBP | Forbudt etter § 5 | 1373918-67-2 | ||
| 4F-α-PHiP | Forbudt etter § 5 | – | ||
| 4F-α-PHP | Forbudt etter § 5 | 2230706-09-7 | ||
| 4F-α-POP | Forbudt etter § 5 | 1829588-09-1 | ||
| 4F-α-PVP | Forbudt etter § 5 | 850352-62-4 | ||
| 4F-α-PVP piperidinanalog | Forbudt etter § 5 | 2131057-86-6 | ||
| 4-HO-DET | 22204-89-3 | |||
| 4-HO-DPT (4-hydroksy-N,N-dipropyltryptamin, deprocin) | Forbudt etter § 5 | 63065-88-3 | ||
| 4-HO-EPT (4-hydroksy-N-etyl-N-propyltryptamin, eprocin) | Forbudt etter § 5 | 2595431-59-5 | ||
| 4-HO-McPT 4-hydroksy-N-metyl-N-syklopropyltryptamin | Forbudt etter § 5 | 2883663-05-4 | ||
| 4-HO-MET | 77872-41-4 | |||
| 4-HO-MiPT | 77872-43-6 | |||
| 4-HO-MPT (4-hydroksy-N-metyl-N-propyltryptamin, meprocin) | Forbudt etter § 5 | 763035-03-6 | ||
| 4-Hydroksy DiPT (4-OH DiPT, 4-HO DiPT, iprocin) | Forbudt etter § 5 | 132328-45-1 | ||
| 4-Hydroksymetkatinon | Forbudt etter § 5 | – | ||
| 4'-Hydroksynitazen (O-desalkyl isotonitazen) | Forbudt etter § 5 | 94758-81-3 | ||
| 4-Klorisobutyrylfentanyl | Forbudt etter § 5 | 244195-34-4 | ||
| 4-Klor-N,N-DMC (4-klor-N,N-dimetylkatinon) | Forbudt etter § 5 | 2493977-47-0 (HCl-salt) | ||
| 4-Klor-N-etylamfetamin | Forbudt etter § 5 | 2275-67-4 | ||
| 4-Klorpentedron | Forbudt etter § 5 | – | ||
| 4-Klor-α-PHP (4-klor-PHP, 4-klor-α-pyrrolidinoheksanofenon, 4-Cl-PHP) | Forbudt etter § 5 | 2748592-28-9 | ||
| 4-Klor-α-PPP | Forbudt etter § 5 | 28117-79-5 | ||
| 4-Klor-α-PVP | Forbudt etter § 5 | 5881-77-6 | ||
| 4-MA | 64-11-9 | |||
| 4-MBC; se benzedron | 1225617-75-3 | |||
| 4-MC (4-metylkatinon, normefedron) | Forbudt etter § 5 | 31952-47-3 | ||
| 4-MEC | P II | Forbudt etter § 5 | 1225617-18-4 | |
| 4-MeMABP | Forbudt etter § 5 | 1336911-98-8 | ||
| 4-MeO-DMT; se 4-metoksy-DMT | 3965-97-7 | |||
| 4-MeO-MiPT (4-metoksy-N-metyl-N-isoproyltryptamin) | Forbudt etter § 5 | 96096-53-6 | ||
| 4-MeOPBP | Forbudt etter § 5 | – | ||
| 4-MeO-α-PVP | Forbudt etter § 5 | 14979-97-6 | ||
| 4-Metoksy PV8 (para-MeO-PV8, 4-metoksy-α-PHPP) | Forbudt etter § 5 | 1801552-04-4 | ||
| 4-Metoksy PV9 (4-metoksy-α-POP) | Forbudt etter § 5 | 1800098-37-6 | ||
| 4-Metoksybutyrylfentanyl | Forbudt etter § 5 | 2088842-68-4 | ||
| 4-Metoksy-DMT | Forbudt etter § 5 | 3965-97-7 | ||
| 4-Metoksyetkatinon | Forbudt etter § 5 | 1225845-30-6 | ||
| 4-Metoksyfuranylfentanyl (para- metoksyfuranylfentanyl) | Forbudt etter § 5 | – | ||
| 4-Metoksy-N,N-dimetyltryptamin; se 4-metoksy-DMT | 3965-97-7 | |||
| 4-Metylbufedron; se 4-MeMABP | 1336911-98-8 | |||
| 4'-Metylheksedron | Forbudt etter § 5 | 2168553-84-0 | ||
| 4-Metylmetkatinon (mefedron) | P II | Forbudt etter § 5 | 1189805-46-6 | |
| 4'-Metyl-N-isopropylpentedron (4'-metyl-NiPP) | Forbudt etter § 5 | 788094-23-5 | ||
| 4-Metyl-α-etylaminopentiofenon | Forbudt etter § 5 | 746540-82-9 | ||
| 4'-Metyl-α-PiHP | Forbudt etter § 5 | 850352-51-1 | ||
| 4'-Metyl-α-pyrrolidinobutiofenon (MPBP) | Forbudt etter § 5 | 732180-91-5 | ||
| 4-MMA | Forbudt etter § 5 | 714965-56-7 | ||
| 4-MPD | Forbudt etter § 5 | 1373918-61-6 | ||
| 4-MTA | P I | Forbudt etter § 5 | 14116-06-4 | |
| 4-Propoksy-3,5-DMPEA (proskalin) | Forbudt etter § 5 | 39201-78-0 | ||
| 5-AcO-DET | Forbudt etter § 5 | – | ||
| 5-DBFPV | Forbudt etter § 5 | 2117405-32-8 | ||
| 5F-ADB; se 5F-MDMB-PINACA | 1715016-75-3 | |||
| 5F-AMB; se 5F-AMB-PINACA | 1715016-74-2 | |||
| 5F-AMB-PINACA | P II | Forbudt etter § 5 | 1715016-74-2 | |
| 5F-APINACA | P II | Forbudt etter § 5 | 1400742-13-3 | |
| 5F-JWH-398 (CL-2201, 4'-kloro-AM-2201, JWH-398 N-fluorpentyl) analog, SGT-20) | Forbudt etter § 5 | 1391486-12-6 | ||
| 5''-Fluor JWH-210; se EAM-2201 | 1364933-60-7 | |||
| 5F-MDMB-2201; se 5F-MDMB-PICA | 1971007-88-1 | |||
| 5F-MDMB-PICA | P II | Forbudt etter § 5 | 1971007-88-1 | |
| 5F-MDMB-PINACA | P II | Forbudt etter § 5 | 1715016-75-3 | |
| 5F-MMB-PINACA; se 5F-AMB-PINACA | 1715016-74-2 | |||
| 5F-PB-22 | P II | Forbudt etter § 5 | 1400742-41-7 | |
| 5-IT | Forbudt etter § 5 | 3784-30-3 | ||
| 5-MAPDB | Forbudt etter § 5 | 1354631-78-9 | ||
| 5-MAPDI | Forbudt etter § 5 | 1310153-27-5 | ||
| 5-MeO-DBT (5-MeO BET, 5-metoksy-N,N-dibutyltryptamin) | Forbudt etter § 5 | 73785-42-9 | ||
| 5-MeO-DiPT | 4021-34-5 | |||
| 5-MeO-DMT | 1019-45-0 | |||
| 5-MeO-EiPT | Forbudt etter § 5 | 850032-66-5 | ||
| 5-MeO-MET | 16977-53-0 | |||
| 5-MeO-MiPT | 96096-55-8 | |||
| 5-Metoksymetylon; se bk-MMDMA | 2230716-98-8 | |||
| 6-AcO-DET | Forbudt etter § 5 | – | ||
| 6-MAM | 2784-73-8 | |||
| 6-Metoksy-MDA (MMDA-2) | Forbudt etter § 5 | 23693-18-7 | ||
| 6-Nikotinoylmorfin (6-mononikotinoylmorfin, morfin 6-nikotinat) | Forbudt etter § 5 | 75533-60-7 | ||
| 7-AcO-DET | Forbudt etter § 5 | – | ||
| 7-hydroksymitragynin (7-HMG) | Forbudt etter § 5 | 174418-82-7 | ||
| α-dimetylaminopentiofenon | Forbudt etter § 5 | 2168229-67-0 | ||
| α-EPP (α-EAPP) | Forbudt etter § 5 | 779974-89-9 | ||
| α-Metyl butyryl fentanyl (2-metyl butyryl fentanyl) | Forbudt etter § 5 | 2748591-35-5 (HCl-salt) | ||
| α-metylfentanyl | N I+IV | Forbudt etter § 5 | 79704-88-4 | |
| α-metyltiofentanyl | N I+IV | Forbudt etter § 5 | 103963-66-2 | |
| α-PBP | 13415-82-2 | |||
| α-PEP (α-PHPP, heptiofenon, PV-8) | Forbudt etter § 5 | 13415-83-3 | ||
| α-PHP | P II | Forbudt etter § 5 | 13415-86-6 | |
| α-PHPP (α-PEP, heptiofenon, PV-8) | Forbudt etter § 5 | 13415-83-3 | ||
| α-PiHP | P II | Forbudt etter § 5 | 2181620-71-1 | |
| α-PNP | Forbudt etter § 5 | 13415-58-2 | ||
| α-POP (PV9) | Forbudt etter § 5 | – | ||
| α-PPP | Forbudt etter § 5 | 19134-50-0 | ||
| α-PVP | P II | Forbudt etter § 5 | 14530-33-7 | |
| α-TMT | Forbudt etter § 5 | 4761-32-4 | ||
| AB-CHMINACA | P II | Forbudt etter § 5 | 1185887-21-1 | |
| AB-FUBINACA | P II | Forbudt etter § 5 | 1185282-01-2 | |
| AB-PINACA | P II | Forbudt etter § 5 | 1445752-09-9 | |
| Acetorfin | N I | Forbudt etter § 5 | 25333-77-1 | |
| Acetyldihydrokodein | N II+III | Unntak fra sertifikatkrav, se § 10 | 3861-72-1 | |
| Acetylfentanyl | N I+IV | Forbudt etter § 5 | 3258-84-2 | |
| Acetylmetadol | N I | 509-74-0 | ||
| Acetyl-α-metylfentanyl | N I+IV | Forbudt etter § 5 | 101860-00-8 | |
| ADB-BUTINACA | P II | Forbudt etter § 5 | 2666932-43-8 | |
| ADB-CHMINACA | P II | Forbudt etter § 5 | 1185887-13-1 | |
| ADB-FUBINACA | P II | Forbudt etter § 5 | 1445583-51-6 | |
| AH-7921 | N I | Forbudt etter § 5 | 55154-30-8 | |
| Akrylfentanyl; se akryloylfentanyl | 82003-75-6 | |||
| Akryloylfentanyl | N I | Forbudt etter § 5 | 82003-75-6 | |
| Alfacetylmetadol | N I | 17199-58-5 | ||
| Alfameprodin | N I | 468-51-9 | ||
| Alfametadol | N I | 17199-54-1 | ||
| Alfaprodin | N I | 77-20-3 | ||
| Alfentanil | N I | 71195-58-9 | ||
| Allobarbital | P IV | 52-43-7 | ||
| Allyleskalin | 39201-75-7 | |||
| Allylprodin | N I | 25384-17-2 | ||
| Alprazolam | P IV | 28981-97-7 | ||
| AM-2201 | P II | Forbudt etter § 5 | 335161-24-5 | |
| AM-2201 2-hydroksyindol metabolitt | Forbudt etter § 5 | 2749391-49-7 | ||
| AM-2201 5-hydroksyindol metabolitt | Forbudt etter § 5 | – | ||
| AM-2201 6-hydroksyindol metabolitt | Forbudt etter § 5 | 1427521-35-4 | ||
| AM-2201 7-hydroksyindol metabolitt | Forbudt etter § 5 | 1537889-11-4 | ||
| AM-2201 kloranalog | – | |||
| AM-2201 N-(3-fluorpentyl) isomer | Forbudt etter § 5 | – | ||
| AM-679 | Forbudt etter § 5 | 335160-91-3 | ||
| AM-694 | 335161-03-0 | |||
| AMB-FUBINACA; se FUB-AMB | 1715016-76-4 | |||
| Amfepramon | P IV | 134-80-5 | ||
| Amfetamin | P II | Forbudt etter § 5 | Tillatelse til rekvirering, se § 5 | 300-62-9 |
| Amineptin | P II | 57574-09-1 | ||
| Aminorex | P IV | Forbudt etter § 5 | 2207-50-3 | |
| Amobarbital | P III | 57-43-2 | ||
| Anileridin | N I | 144-14-9 | ||
| Aprobarbital | 77-02-1 | |||
| β-hydroksy-3-metylfentanyl (ohmefentanyl) | N I+IV | Forbudt etter § 5 | 78995-14-9 | |
| β-hydroksyfentanyl | N I+IV | Forbudt etter § 5 | 78995-10-5 | |
| β-hydroksytiofentanyl | Forbudt etter § 5 | 1474-34-6 | ||
| β-metylfentanyl | Forbudt etter § 5 | 79146-56-8 | ||
| Barbital | P IV | 57-44-3 | ||
| BDB | Forbudt etter § 5 | 107447-03-0 | ||
| Bentazepam | 29462-18-8 | |||
| Benzedron (4-MBC) | Forbudt etter § 5 | 1225617-75-3 | ||
| Benzetidin | N I | 3691-78-9 | ||
| Benzfetamin | P IV | Forbudt etter § 5 | 156-08-1 | |
| Benzoylekgonin | N I | 519-09-5 | ||
| Benzoylfentanyl | Forbudt etter § 5 | 2309383-15-9 | ||
| Benzylmorfin | N I | 14297-87-1 | ||
| Betacetylmetadol | N I | 17199-59-6 | ||
| Betameprodin | N I | 468-50-8 | ||
| Betametadol | N I | 17199-55-2 | ||
| Betaprodin | N I | 468-59-7 | ||
| Bezitramid | N I | 15301-48-1 | ||
| bk-3,4-MDPA (propylon) | Forbudt etter § 5 | 201474-93-3 | ||
| bk-6-metoksy-MDMA | Forbudt etter § 5 | – | ||
| bk-DMBDB (dibutylon) | 802286-83-5 | |||
| bk-EBDB (eutylon) | P II | Forbudt etter § 5 | 802855-66-9 | |
| bk-IMP | Forbudt etter § 5 | 100608-69-3 | ||
| bk-IVP | Forbudt etter § 5 | – | ||
| bk-MBDB (butylon) | Forbudt etter § 5 | 802575-11-7 | ||
| bk-MDDMA (dimetylon) | 765231-58-1 | |||
| bk-MDEA (etylon) | P II | Forbudt etter § 5 | 1112937-64-0 | |
| bk-MDMA (metylon) | P II | Forbudt etter § 5 | 186028-79-5 | |
| bk-MMDMA (5-metoksymetylon) | Forbudt etter § 5 | 2230716-98-8 | ||
| bk-PBDB (putylon) | 802286-81-3 | |||
| bk-PMMA (metedron) | 530-54-1 | |||
| BMDB | Forbudt etter § 5 | 1823865-05-9 (HCl-salt) | ||
| BMDP (benzylon) | Forbudt etter § 5 | 1823274-68-5 | ||
| Brifentanil (brifentanyl, A-3331) | Forbudt etter § 5 | 101345-71-5 | ||
| Brolamfetamin (DOB) | P I | Forbudt etter § 5 | 64638-07-9 | |
| Bromazepam | P IV | 1812-30-2 | ||
| Bromazolam | P IV | Forbudt etter § 5 | 71368-80-4 | |
| Brombenzo-difuranyl-isopropylamin (bromo-DragonFLY) | Forbudt etter § 5 | 502759-67-3 | ||
| Brorfin | N I | Forbudt etter § 5 | 2244737-98-0 | |
| Brotizolam | P IV | 57801-81-7 | ||
| Bufedron; se MABP | 408332-79-6 | |||
| Bufotenin (5-HO-DMT) | Forbudt etter § 5 | 487-93-4 | ||
| Buprenorfin | P III | 52485-79-7 | ||
| Butalbital | P III | 77-26-9 | ||
| Butobarbital | P IV | 77-28-1 | ||
| Butonitazen (butoksynitazen) | N I | Forbudt etter § 5 | 95810-54-1 | |
| Butylon; se bk-MBDB | 802575-11-7 | |||
| Butyrfentanyl (butyrylfentanyl) | N I | Forbudt etter § 5 | 1169-70-6 | |
| Camazepam | P IV | 36104-80-0 | ||
| Cannabis (med cannabis menes de overjordiske deler av alle vekster av slekten cannabis (unntatt frøene), hvis harpiksen ikke er ekstrahert) | N I+IV | Forbudt etter § 5 | ||
| Cannabisharpiks | N I+IV | Forbudt etter § 5 | ||
| Catha edulis (khat) | Forbudt etter § 5 | |||
| Clobazam | P IV | 22316-47-8 | ||
| Clobenzorex | 13364-32-4 | |||
| Clotiazepam | P IV | 33671-46-4 | ||
| Cloxazolam | P IV | 24166-13-0 | ||
| Cocablad | N I | |||
| Codeine Impurity D (EP) (3-O-(kodein-2-yl)morfin) | Forbudt etter § 5 | 2585669-81-2 | ||
| Codoxim | N I | 7125-76-0 | ||
| CP 47,497 | 70434-82-1 | |||
| CP 47,497-C8-homolog | Forbudt etter § 5 | 70434-92-3 | ||
| CP 55,940 | Forbudt etter § 5 | 83002-04-4 | ||
| CUMYL-4CN-BINACA | P II | Forbudt etter § 5 | 1631074-54-8 | |
| CUMYL-PEGACLONE | P II | Forbudt etter § 5 | 2160555-55-3 | |
| Dekstroamfetamin (Dexamfetamine) | P II | Forbudt etter § 5 | Tillatelse til rekvirering, se § 5 | 51-64-9 |
| Dekstropropoksifen | N I+III | Unntak fra sertifikatkrav, se § 10 | 469-62-5 | |
| Delorazepam | P IV | 2894-67-9 | ||
| delta-6a(7)-THC; se tetrahydrocannabinol | 59042-44-3 | |||
| delta-6a(10a)-THC; se tetrahydrocannabinol | 7663-50-5 | |||
| delta-7-THC; se tetrahydrocannabinol | 42793-13-5 | |||
| delta-8-THC; se tetrahydrocannabinol | 5957-75-5 | |||
| delta8-THC acetat (Δ8-tetrahydrocannabinol acetat, Δ8-THC-O-acetat) | Forbudt etter § 5 | 23050-54-6 | ||
| delta-9-tetrahydrocannabinol; se dronabinol | 1972-08-3 | |||
| delta9-THC acetat (Δ9-tetrahydrocannabinol acetat, THC-O-acetat) | Forbudt etter § 5 | 23132-17-4 | ||
| delta-9(11)-THC; se tetrahydrocannabinol | 27179-28-8 | |||
| delta-10-THC; se tetrahydrocannabinol | 7663-51-6 | |||
| Desomorfin | N I+IV | Forbudt etter § 5 | 427-00-9 | |
| DET | P I | Forbudt etter § 5 | 61-51-8 | |
| Dextromoramid | N I | 357-56-2 | ||
| Diacetylmorfin; se heroin | 561-27-3 | |||
| Diampromid | N I | 552-25-0 | ||
| Diazepam | P IV | 439-14-5 | ||
| Dibutylon; se bk-DMBDB | 802286-83-5 | |||
| Diclazepam | P IV | Forbudt etter § 5 | 2894-68-0 | |
| Dietyltiambuten | N I | 86-14-6 | ||
| Difenidin | P II | Forbudt etter § 5 | 36794-52-2 | |
| Difenoksin | N I | 28782-42-5 | ||
| Difenoksylat | N I+III | Unntak fra sertifikatkrav, se § 10 | 915-30-0 | |
| Dihydroetorfin | N I | 14357-76-7 | ||
| Dihydrokodein | N II+III | Unntak fra sertifikatkrav, se § 10 | 125-28-0 | |
| Dihydromorfin | N I | 509-60-4 | ||
| Dimenoxadol | N I | 509-78-4 | ||
| Dimepheptanol | N I | 545-90-4 | ||
| Dimetyltiambuten | N I | 524-84-5 | ||
| Dioksafetylbutyrat | N I | 467-86-7 | ||
| Dipipanon | N I | 467-83-4 | ||
| DiPT | 14780-24-6 | |||
| DL-4662 | Forbudt etter § 5 | – | ||
| DMA (2,5-DMA) | P I | Forbudt etter § 5 | 2801-68-5 | |
| DMHP | P I | Forbudt etter § 5 | 32904-22-6 | |
| DMT | P I | Forbudt etter § 5 | 61-50-7 | |
| D-norpseudoefedrin; se katin | 492-39-7 | |||
| DOB; se brolamfetamin | 64638-07-9 | |||
| DOC | P I | Forbudt etter § 5 | 123431-31-2 | |
| DOET | P I | Forbudt etter § 5 | 22004-32-6 | |
| DOI | 42203-78-1 | |||
| DOM | P I | Forbudt etter § 5 | 15588-95-1 | |
| DOPR | Forbudt etter § 5 | 63779-88-4 | ||
| DOT (Aleph) | Forbudt etter § 5 | 61638-07-1 | ||
| DPT | 61-52-9 | |||
| Dronabinol | P II | Forbudt etter § 5 | 1972-08-3 | |
| Drotebanol | N I | 3176-03-2 | ||
| EAM-2201 (5-fluor JWH-210) | Forbudt etter § 5 | 1364933-60-7 | ||
| Efylon; se N-etylpentylon | 727641-67-0 | |||
| Ekgonin | N I | 481-37-8 | ||
| Eskalin | 39201-82-6 | |||
| Esketamin (S-ketamin) | 33643-46-8 | |||
| Estazolam | P IV | 29975-16-4 | ||
| Eszopiklon (S-zopiklon) | 138729-47-2 | |||
| Etazen | N I | Forbudt etter § 5 | 14030-76-3 | |
| Eticyclidin (PCE) | P I | Forbudt etter § 5 | 2201-15-2 | |
| Etilamfetamin | P IV | 457-87-4 | ||
| Etinamat | P IV | 126-52-3 | ||
| Etizolam | P IV | 40054-69-1 | ||
| Etkatinon (N-etylkatinon) | 18259-37-5 | |||
| Etklorvynol | P IV | 113-18-8 | ||
| Etometazen (5-metyl etodesnitazen, 5-metyldesnitroetonitazen, eto) | Forbudt etter § 5 | 95293-25-7 | ||
| Etonitazen | N I | 911-65-9 | ||
| Etonitazepipne (N-piperidino etonitazen) | N I | Forbudt etter § 5 | 734496-28-7 | |
| Etonitazepyn | N I | Forbudt etter § 5 | – | |
| Etorfin | N I | Forbudt etter § 5 | 14521-96-1 | |
| Etoxeridin | N I | 469-82-9 | ||
| Etryptamin | P I | Forbudt etter § 5 | 2235-90-7 | |
| Etyl morfin 6-β-D-glukuronid | Forbudt etter § 5 | 168074-32-6 | ||
| Etylfenidat | P II | Forbudt etter § 5 | 57413-43-1 | |
| Etylloflazepat | P IV | 29177-84-2 | ||
| Etylmetyltiambuten | N I | 441-61-2 | ||
| Etylmorfin | N II+III | Unntak fra sertifikatkrav, se § 10 | 76-58-4 | |
| Etylmorfin-6-glukuronid | Forbudt etter § 5 | – | ||
| Etylon (bk-MDEA) | P II | Forbudt etter § 5 | 1112937-64-0 | |
| Etylpropyltryptamin (N-etyl-N-propyltryptamin, EPT) | Forbudt etter § 5 | 850032-68-7 | ||
| Eutylon; se bk-EBDB | 802855-66-9 | |||
| Fenadokson | N I | 467-84-5 | ||
| Fenampromid | N I | 129-83-9 | ||
| Fenaridin (2,5-dimetylfentanyl) | Forbudt etter § 5 | 42045-97-6 | ||
| Fenazepam | P IV | 51753-57-2 | ||
| Fenazokin | N I | 127-35-5 | ||
| Fencamfamin | P IV | 1209-98-9 | ||
| Fendimetrazin | P IV | Forbudt etter § 5 | 634-03-7 | |
| Fenetyllin | P II | Forbudt etter § 5 | 3736-08-1 | |
| Fenfluramin | 458-24-2 | |||
| Fenibut (Phenibut) | 1078-21-3 | |||
| Fenmetrazin | P II | 134-49-6 | ||
| Fenobarbital | P IV | 50-06-6 | ||
| Fenomorfan | N I | 468-07-5 | ||
| Fenoperidin | N I | 562-26-5 | ||
| Fenproporex | P IV | 16397-28-7 | ||
| Fensyklidin (PCP) | P II | Forbudt etter § 5 | 77-10-1 | |
| Fentanyl | N I | 437-38-7 | ||
| Fentermin | P IV | Forbudt etter § 5 | 122-09-8 | |
| Flefedron; se 4-FMC | 447-40-5 | |||
| Flualprazolam | P IV | 28910-91-0 | ||
| Flubromazolam | P IV | Forbudt etter § 5 | 612526-40-6 | |
| Fludiazepam | P IV | 3900-31-0 | ||
| Flunitazen (fluonitazen) | Forbudt etter § 5 | 2249-36-7 | ||
| Flunitrazepam | P III | 1622-62-4 | ||
| Flurazepam | P IV | 17617-23-1 | ||
| Folkodin | N II + III | Unntak fra sertifikatkrav, se § 10 | 509-67-1 | |
| FUB-AMB (AMB-FUBINACA, MMB-FUBINACA) | P II | Forbudt etter § 5 | 1715016-76-4 | |
| Furanyletylfentanyl | Forbudt etter § 5 | 802544-02-1 | ||
| Furanylfentanyl | N I | Forbudt etter § 5 | 101345-66-8 | |
| Furetidin | N I | 2385-81-1 | ||
| Gammabutyrolakton (GBL) | 96-48-0 | |||
| Gammahydroksybutyrat (GHB) | P II | 591-81-1 | ||
| Glutetimid | P III | 77-21-4 | ||
| Halazepam | P IV | 23092-17-3 | ||
| Haloksazolam | P IV | 59128-97-1 | ||
| Heksedron; se 2-(metylamino)-1-fenylheksan-1-on | 2169446-41-5 | |||
| Heksobarbarbital | 56-29-1 | |||
| Heksylon | – | |||
| Heptabarbital (heptabarb) | 509-86-4 | |||
| Heroin | N I+IV | Forbudt etter § 5 | 561-27-3 | |
| Hexahydrocannabinol (HHC) | P II | Forbudt etter § 5 | 6692-85-9 | |
| Hydrokodon | N I | 125-29-1 | ||
| Hydroksypetidin | N I | 468-56-4 | ||
| Hydromorfinol | N I | 2183-56-4 | ||
| Hydromorfon | N I | 466-99-9 | ||
| Iso-butonitazen | Forbudt etter § 5 | – | ||
| Isobutyrylfentanyl (isobutyrfentanyl) | Forbudt etter § 5 | 119618-70-1 | ||
| Isoheksedron (α-methylaminoisoheksanofenon) | Forbudt etter § 5 | – | ||
| Isoheksylon (3,4-metylendioksy-α-metylaminoisoheksanofenon) | Forbudt etter § 5 | 1157947-89-1 | ||
| Isometadon | N I | 466-40-0 | ||
| Isotonitazen | N I | Forbudt etter § 5 | 14188-81-9 | |
| JWH-007 | 155471-10-6 | |||
| JWH-011 | 155471-13-9 | |||
| JWH-015 | 155471-08-2 | |||
| JWH-016 | 155471-09-3 | |||
| JWH-018 | P II | Forbudt etter § 5 | 209414-07-3 | |
| JWH-018 2-hydroksyindol metabolitt | Forbudt etter § 5 | 1427325-32-3 | ||
| JWH-019 | 209414-08-4 | |||
| JWH-020 | 209414-09-5 | |||
| JWH-022 | 209414-16-4 | |||
| JWH-030 | 162934-73-8 | |||
| JWH-031 | 162934-74-9 | |||
| JWH-047 | 316189-65-8 | |||
| JWH-048 | 316189-66-9 | |||
| JWH-071 | 209414-05-1 | |||
| JWH-072 | 209414-06-2 | |||
| JWH-073 | Forbudt etter § 5 | 208987-48-8 | ||
| JWH-081 | Forbudt etter § 5 | 210179-46-7 | ||
| JWH-098 | 316189-74-9 | |||
| JWH-116 | 619294-64-3 | |||
| JWH-120 | 824955-98-8 | |||
| JWH-122 | Forbudt etter § 5 | 619294-47-2 | ||
| JWH-122N-(4-pentenyl) analog (MAM2201 N-(4-pentenyl) analog, JWH 022 4-metylnaftyl analog) | Forbudt etter § 5 | 1445577-68-3 | ||
| JWH-122N-(5-brompentyl) analog | Forbudt etter § 5 | – | ||
| JWH-122N-(5-iodpentyl) analog | Forbudt etter § 5 | – | ||
| JWH-145 | 914458-19-8 | |||
| JWH-147 | 914458-20-1 | |||
| JWH-148 | 824955-99-9 | |||
| JWH-149 | 548461-82-1 | |||
| JWH-164 | 824961-61-7 | |||
| JWH-166 | 824961-41-3 | |||
| JWH-167 | 864445-37-4 | |||
| JWH-171 | – | |||
| JWH-175 | 619294-35-8 | |||
| JWH-176 | 619294-62-1 | |||
| JWH-180 | 824959-87-7 | |||
| JWH-181 | 824960-03-4 | |||
| JWH-182 | 824960-02-3 | |||
| JWH-184 | 619294-37-0 | |||
| JWH-185 | 619294-39-2 | |||
| JWH-192 | – | |||
| JWH-193 | 133438-58-1 | |||
| JWH-194 | – | |||
| JWH-195 | – | |||
| JWH-196 | 619294-41-6 | |||
| JWH-197 | – | |||
| JWH-198 | 166599-76-4 | |||
| JWH-199 | – | |||
| JWH-200 | 103610-04-4 | |||
| JWH-201 | 864445-47-6 | |||
| JWH-203 | Forbudt etter § 5 | 864445-54-5 | ||
| JWH-205 | – | |||
| JWH-210 | Forbudt etter § 5 | 824959-81-1 | ||
| JWH-250 | Forbudt etter § 5 | 864445-43-2 | ||
| JWH-251 | 864445-39-6 | |||
| JWH-302 | Forbudt etter § 5 | 864445-45-4 | ||
| JWH-307 | Forbudt etter § 5 | 914458-26-7 | ||
| JWH-308 | Forbudt etter § 5 | – | ||
| JWH-309 | Forbudt etter § 5 | 914458-42-7 | ||
| JWH-368 | Forbudt etter § 5 | 914458-31-4 | ||
| JWH-369 | Forbudt etter § 5 | 914458-27-8 | ||
| JWH-398 | 1292765-18-4 | |||
| Karfentanil | N I+IV | Forbudt etter § 5 | 59708-52-0 | |
| Karisoprodol (carisoprodol) | P IV | 78-44-4 | ||
| Katin (D-norpseudoefedrin) | P III | 492-39-7 | ||
| Katinon | P I | Forbudt etter § 5 | 71031-15-7 | |
| Ketamin | 6740-88-1 | |||
| Ketazolam | P IV | 27223-35-4 | ||
| Ketobemidon | N I+IV | 469-79-4 | ||
| Khat; se Catha edulis | ||||
| Klefedron; se 4-CMC | 1225843-86-6 | |||
| Klofedron; se 3-CMC | P II | 1049677-59-9 | ||
| Klonazepam | P IV | 1622-61-3 | ||
| Klonazolam | P IV | Forbudt etter § 5 | 33887-02-4 | |
| Klonitazen | N I | 3861-76-5 | ||
| Klorazepat | P IV | 23887-31-2 | ||
| Klordiazepoksid | P IV | 58-25-3 | ||
| Klorfentermin | Forbudt etter § 5 | 461-78-9 | ||
| Kodein | N II+III | Unntak fra sertifikatkrav, se § 10 | 76-57-3 | |
| Kodein-N-oksid | 3688-65-1 | |||
| Koka-blad; se cocablad | ||||
| Kokain | N I | 50-36-2 | ||
| Kratom (Mitragyna speciosa) | Forbudt etter § 5 | |||
| Krotonylfentanyl | N I | Forbudt etter § 5 | 760930-59-4 | |
| Lefetamin | P IV | Forbudt etter § 5 | 7262-75-1 | |
| Levoamfetamin (levamfetamin) | P II | Forbudt etter § 5 | 156-34-3 | |
| Levofenacylmorfan | N I | 10061-32-2 | ||
| Levometamfetamin | P II | Forbudt etter § 5 | 33817-09-3 | |
| Levometorfan | N I | 125-70-2 | ||
| Levomoramid | N I | 5666-11-5 | ||
| Levorfanol | N I | 77-07-6 | ||
| Lisdeksamfetamin | Forbudt etter § 5 | Tillatelse til rekvirering, se § 5 | 608137-32-2 | |
| Lofentanil (lofentanyl) | Forbudt etter § 5 | 61380-40-3 | ||
| Loprazolam | P IV | 61197-73-7 | ||
| Lorazepam | P IV | 846-49-1 | ||
| Lormetazepam | P IV | 848-75-9 | ||
| LSD; se lysergide | 50-37-3 | |||
| Lysergide | P I | Forbudt etter § 5 | 50-37-3 | |
| MAB-CHMINACA; se ADB-CHMINACA | 1185887-13-1 | |||
| MABP (bufedron) | 408332-79-6 | |||
| MAL (metallyleskalin) | Forbudt etter § 5 | 207740-41-8 | ||
| MAM-2201 | 1354631-24-5 | |||
| MAM-2201 N-(3-fluorpentyl) analog | Forbudt etter § 5 | – | ||
| MAM-2201 N-(5-klorpentyl) analog | Forbudt etter § 5 | 1445578-25-5 | ||
| Mazindol | P IV | Forbudt etter § 5 | 22232-71-9 | |
| MBDB | Forbudt etter § 5 | 135795-90-3 | ||
| mCPP; se 1-(3-klorfenyl)-piperazin | 6640-24-0 | |||
| MDA; se tenamfetamin | 4764-17-4 | |||
| MDMA (ecstacy) | P I | Forbudt etter § 5 | 42542-10-9 | |
| MDMB-4en-PINACA | P II | Forbudt etter § 5 | 2504100-70-1 | |
| MDMB-CHMICA | P II | Forbudt etter § 5 | 1863065-84-2 | |
| MDMB-FUBINACA | P II | Forbudt etter § 5 | 1971007-93-8 | |
| MDPHP; se 3',4'-MDPHP | 776994-64-0 | |||
| MDPPP | Forbudt etter § 5 | 783241-66-7 | ||
| MDPT(tBuONE) (D-tertylon) | Forbudt etter § 5 | 2469270-98-0 (HCl-salt) | ||
| MDPV | P II | Forbudt etter § 5 | 687603-66-3 | |
| Mecloqualon | P II | 340-57-8 | ||
| Medazepam | P IV | 2898-12-6 | ||
| Mefedron; se 4-metylmetkatinon | 1189805-46-6 | |||
| Mefenorex | P IV | 17243-57-1 | ||
| Menitazen (Metylnitazen) | Forbudt etter § 5 | 95282-00-1 | ||
| Meprobamat | P IV | 57-53-4 | ||
| Meskalin | P I | Forbudt etter § 5 | 54-04-6 | |
| Mesocarb | P IV | Forbudt etter § 5 | 34262-84-5 | |
| MET | 5599-69-9 | |||
| Metadon | N I | 76-99-3 | ||
| Metadon-intermediat | N I | 125-79-1 | ||
| Metafedrin (3-metylmetamfetamin, 3-MMA) | Forbudt etter § 5 | 861007-68-3 | ||
| Metafluorfentanyl; se 3-fluorfentanyl | – | |||
| Metakrylfentanyl | Forbudt etter § 5 | – | ||
| Metakvalon | P II | 72-44-6 | ||
| Metamfepramon (dimepropion, N,N-DMC, dimetylkatinon) | Forbudt etter § 5 | 15351-09-4 | ||
| Metamfetamin | P II | Forbudt etter § 5 | 537-46-2 | |
| Metarbital | 50-11-3 | |||
| Metazocin | N I | 3734-52-9 | ||
| Metedron; se bk-PMMA | 530-54-1 | |||
| Metkatinon | P I | Forbudt etter § 5 | 5650-44-2 (R-form) 112117-24-5 (S-form) | |
| Metodesnitazen (metazen) | Forbudt etter § 5 | 14030-77-4 | ||
| Metoheksital | 151-83-7 | |||
| Metoksetamin (MXE) | P II | Forbudt etter § 5 | 1239943-76-0 | |
| Metoksyacetylfentanyl (MAF) | N I | Forbudt etter § 5 | 101345-67-9 | |
| Metonitazen | N I | Forbudt etter § 5 | 14680-51-4 | |
| Metopon | N I | 143-52-2 | ||
| Metylallyleskalin; se MAL | 207740-41-8 | |||
| Metylaminorex (4-metylaminorex) | P I | Forbudt etter § 5 | 3568-94-3 | |
| Metyldesorfin | N I | Forbudt etter § 5 | 16008-36-9 | |
| Metyldihydromorfin | N I | 509-56-8 | ||
| Metylendioksykatinon (3,4-metylendioksykatinon, MDC, nitrilon, amylon, βk-MDA) | Forbudt etter § 5 | 80535-73-5 | ||
| Metylfenidat | P II | Forbudt etter § 5 | Tillatelse til rekvirering, se § 5 | 113-45-1 |
| Metylfenobarbital | P IV | 115-38-8 | ||
| Metylon; se bk-MDMA | 186028-79-5 | |||
| Metyprylon | P IV | 125-64-4 | ||
| MFPVP (4-fluor-3-metyl-α-pyrrolidinovalerofenon) | Forbudt etter § 5 | – | ||
| Midazolam | P IV | 59467-70-8 | ||
| Mitragynin | Forbudt etter § 5 | 4098-40-2 | ||
| MMB-FUBINACA; se FUB-AMB | 1715016-76-4 | |||
| MMDA | P I | Forbudt etter § 5 | 13674-05-0 | |
| MMDA-2; se 6-metoksy-MDA | 23693-18-7 | |||
| MOPPP | Forbudt etter § 5 | 478243-09-3 | ||
| Moramid-intermediat | N I | 3626-55-9 | ||
| Morferidin | N I | 469-81-8 | ||
| Morfin | N I | 57-27-2 | ||
| Morfinmetobromid (morfinmetylbromid) og andre 5-verdige nitrogen-morfinderivater | N I | 125-23-5 | ||
| Morfin-N-oksid | N I | 639-46-3 | ||
| MPA (metiopropamin) | P II | Forbudt etter § 5 | 801156-47-8 | |
| MPHP | Forbudt etter § 5 | 34138-58-4 | ||
| MPPP (4-MePPP) | Forbudt etter § 5 | 28117-80-8 | ||
| MPPP (desmetylprodin) | N I+IV | Forbudt etter § 5 | 13147-09-6 | |
| MT-45 | N I | Forbudt etter § 5 | 41537-67-1 | |
| Myrofin | N I | 467-18-5 | ||
| N,N-dietylheksedron(α -dietylaminoheksanofenon) | Forbudt etter § 5 | – | ||
| N,N-dietylpentylon | Forbudt etter § 5 | 801171-27-7 | ||
| N,N-dimetylpentylon (dipentylon) | P II | Forbudt etter § 5 | 803614-36-0 | |
| N-butyl bufedron (N-butyl BP, NBB, α-butylaminobutiofenon, N-butyl norbufedron) | Forbudt etter § 5 | – | ||
| N-butylbutylon (N-butylnorbutylon, 3,4-metylendioksy-α-butylaminobutiofenon) | Forbudt etter § 5 | – | ||
| N-Butylheksedron (α-butylaminoheksanofenon) | Forbudt etter § 5 | 802576-87-0 | ||
| N-Butylheptedron | Forbudt etter § 5 | – | ||
| N-butyl-N-metyl butylon (3,4-metylendioksy-α-butylmetylaminobutiofenon) | Forbudt etter § 5 | – | ||
| N-butylpentylon (metylendioksybutylvalerofenon, MDBVP) | Forbudt etter § 5 | 688727-54-0 | ||
| N-desetyl etonitazen (NDE, noretonitazen) | Forbudt etter § 5 | 2732926-26-8 | ||
| N-desetyletonitazen | N I | Forbudt etter § 5 | ||
| N-desetylisotonitazen (norisotonitazen) | N I | Forbudt etter § 5 | 2732926-24-6 | |
| NEB (N-etylbufedron) | 1354631-28-9 | |||
| N-etyl 2C-B | Forbudt etter § 5 | 155639-24-0 | ||
| N-etylamfetamin; se etilamfetamin | 457-87-4 | |||
| N-etylheksedron | P II | Forbudt etter § 5 | 802857-66-5 | |
| N-Etylheksylon | Forbudt etter § 5 | 802605-02-3 | ||
| N-etylheptedron | Forbudt etter § 5 | – | ||
| N-etylheptylon | Forbudt etter § 5 | – | ||
| N-etylisoheksedron | Forbudt etter § 5 | – | ||
| N-etyl-N-metyl butylon (3,4-metylendioksy-α-etylmetylaminobutiofenon) | Forbudt etter § 5 | – | ||
| N-etylnorpentylon; se N-etylpentylon | 727641-67-0 | |||
| N-etylpentedron (NEP) | Forbudt etter § 5 | 779974-89-9 | ||
| N-etylpentylon (efylon) | P II | Forbudt etter § 5 | 727641-67-0 | |
| N-etyltenamfetamin | P I | Forbudt etter § 5 | – | |
| N-hydroksytenamfetamin (MDOH, MDH) | P I | Forbudt etter § 5 | 74698-47-8 | |
| Nikodikodin (nikodikodein) | N II+III | Unntak fra sertifikatkrav, se § 10 | 808-24-2 | |
| Nikokodin (nikokodein) | N II+III | Unntak fra sertifikatkrav, se § 10 | 3688-66-2 | |
| Nikomorfin | N I | 639-48-5 | ||
| Nimetazepam | P IV | 2011-67-8 | ||
| N-isobutylheksedron (α-isobutylaminoheksanofenon, NDH) | Forbudt etter § 5 | – | ||
| Nitrazepam | P IV | 146-22-5 | ||
| N-Me-2C-B | Forbudt etter § 5 | – | ||
| N-Me-2C-H | Forbudt etter § 5 | 13063-01-9 (HCl-salt) | ||
| N-metyl-bk-MMDA-2; se bk-6-metoksy-MDMA | – | |||
| N-metyletylon (N-etylmetylon, 3,4-metylendioksy-N-etyl-N-metylkatinon) | Forbudt etter § 5 | 2703646-17-5 (HCl-salt) | ||
| N-metylheksylon; se heksylon | – | |||
| N-metyl-N-propyl metylon (3,4-metylendioksy-α-metylpropylaminopropiofenon, 3,4-metylendioksy-N-propylmetkatinon, N-propyl metylon, N-metyl propylon) | Forbudt etter § 5 | – | ||
| N-metyltryptamin (NMT) | 61-49-4 | |||
| NMT; se N-metyltryptamin | 61-49-4 | |||
| Noracymetadol | N I | 1477-39-0 | ||
| Nordazepam | P IV | 1088-11-5 | ||
| Norkodein | N II+III | Unntak fra sertifikatkrav, se § 10 | 467-15-2 | |
| Norkodein-6-glukuronid (norkodein-O-b-D-glukuronid) | Forbudt etter § 5 | – | ||
| Norlevorfanol | N I | 1531-12-0 | ||
| Normefedron; se 4-MC | 31952-47-3 | |||
| Normetadon | N I | 467-85-6 | ||
| Normorfin | N I | 466-97-7 | ||
| Norpipanon | N I | 561-48-8 | ||
| N-pentylmetylon (3,4-metylendioksy-N-pentylkatinon) | Forbudt etter § 5 | – | ||
| N-propyl bufedron (N-propylnorbufedron, N-propyl BP, NBP) | Forbudt etter § 5 | 18267-91-9 (HCl-salt) | ||
| N-propyl-N-metyl butylon (3,4-metylendioksy-α-propylmetylaminobutiofenon) | Forbudt etter § 5 | – | ||
| N-propylnorpentedron | Forbudt etter § 5 | – | ||
| N-pyrrolidino isotonitazen | N I | Forbudt etter § 5 | ||
| N-pyrrolidino metonitazen (metonitazepyn) | N I | Forbudt etter § 5 | – | |
| N-sec-butyl pentedron (2-(sec-butylamino)-valerofenon) | Forbudt etter § 5 | 18268-12-7 (HCl-salt) | ||
| Ocfentanil | N I | Forbudt etter § 5 | 101343-69-5 | |
| Oksazepam | P IV | 604-75-1 | ||
| Oksazolam | P IV | 24143-17-7 | ||
| Oksykodon | N I | 76-42-6 | ||
| Oksymorfon | N I | 76-41-5 | ||
| Oksymorfon-3-β-D- glukuronid | Forbudt etter § 5 | 770735-01-8 | ||
| Opium | N I | |||
| Oripavin | N I | 467-04-9 | ||
| Ortofluorfentanyl; se 2-fluorfentanyl | 910616-29-4 | |||
| Orto-fluorfuranylfentanyl (2-fluor furanyl fentanyl) | Forbudt etter § 5 | 2749619-19-8 (HCl-salt) | ||
| Ortometylacetylfentanyl; se 2-metylacetylfentanyl | – | |||
| Panaeolus cyanescens (Blånende flekkskivesopp) (herunder bl.a. soppsporer og dyrkede, tørkede eller på annen måte bearbeidede sopper) | Forbudt etter § 5 | |||
| Para-bromamfetamin (PBA, 4-bromamfetamin (4-BA)) | Forbudt etter § 5 | 18455-37-3 | ||
| Parafluorbutyrfentanyl; se 4-fluorbutyrfentanyl | 244195-31-1 | |||
| Parafluorfentanyl | N I+IV | Forbudt etter § 5 | 90736-23-5 | |
| Para-fluorfuranylfentanyl (4-fluor furanyl fentanyl) | Forbudt etter § 5 | 1802489-71-9 | ||
| Paraheksyl (synheksyl) | P I | Forbudt etter § 5 | 117-51-1 | |
| Para-klor metoksyacetyl fentanyl (4-klormetoksyacetylfentanyl) | Forbudt etter § 5 | 101345-75-9 (HCl-salt) | ||
| Para-klorfentanyl | Forbudt etter § 5 | 117994-27-1 (HCl-salt) | ||
| Para-metoksy metoksyacetyl fentanyl | Forbudt etter § 5 | 2748289-90-7 (HCl-salt) | ||
| Parametoksyfuranylfentanyl; se 4-metoksyfuranylfentanyl | – | |||
| Parametoksymetamfetamin (PMMA) | P I | Forbudt etter § 5 | 22331-70-0 | |
| Para-metylsyklopropylfentanyl (4-metyl syklopropyl fentanyl) | Forbudt etter § 5 | 2749910-43-6 (HCl-salt) | ||
| PCE; se eticyclidin | 2201-15-2 | |||
| PCPy; se rolicyclidin | 2201-39-0 | |||
| Pemolin | P IV | 2152-34-3 | ||
| Pentazocin | P III | 359-83-1 | ||
| Pentedron | P II | Forbudt etter § 5 | 879722-57-3 | |
| Pentobarbital | P III | 76-74-4 | ||
| Pentylon | Forbudt etter § 5 | 698963-77-8 | ||
| PEPAP | N I+IV | Forbudt etter § 5 | 64-52-8 | |
| Petidin – intermediat A, intermediat B (norpetidin), intermediat C (petidinsyre) | N I | 3627-62-1 77-17-8 3627-48-3 | ||
| Petidin (meperidin) | N I | 57-42-1 | ||
| Piminodin | N I | 13495-09-5 | ||
| Pinazepam | P IV | 52463-83-9 | ||
| Pipradrol | P IV | Forbudt etter § 5 | 467-60-7 | |
| Piritramid | N I | 302-41-0 | ||
| PMA (para-metoksyamfetamin | P I | Forbudt etter § 5 | 64-13-1 | |
| PMMA (4-MMA); se para-metoksymetamfetamin | 22331-70-0 | |||
| Poppy straw (valmuehalm) | N I | |||
| Prazepam | P IV | 2955-38-6 | ||
| Proheptazin | N I | 77-14-5 | ||
| Properidin | N I | 561-76-2 | ||
| Propiram | N II | 15686-91-6 | ||
| Propylkatinon (α-propylaminopropiofenon, N-propylkatinon) | Forbudt etter § 5 | 879667-46-6 (HCl-salt) | ||
| Propylnitazen | Forbudt etter § 5 | 118899-22-2 (HCl-salt) | ||
| Propylon; se bk-3,4-MDPA | 201474-93-3 | |||
| Proskalin; se 4-propoksy-3,5-DMPEA | 39201-78-0 | |||
| Protonitazen | N I | Forbudt etter § 5 | 95958-84-2 | |
| Protonitazepyn (N-pyrrolidino protonitazen) | N I | Forbudt etter § 5 | 3038401-95-2 | |
| Psilocin (4-HO-DMT) | P I | Forbudt etter § 5 | 520-53-6 | |
| Psilocin-O-glukuronid (psilocin glukuronid) | Forbudt etter § 5 | 514212-83-0 | ||
| Psilocybe cubensis (Cubafleinsopp) (herunder bl.a. soppsporer og dyrkede, tørkede eller på annen måte bearbeidede sopper) | Forbudt etter § 5 | |||
| Psilocybe semilanceata (Spiss fleinsopp) (herunder bl.a. soppsporer og dyrkede, tørkede eller på annen måte bearbeidede sopper) | Forbudt etter § 5 | |||
| Psilocybin | P I | Forbudt etter § 5 | 520-52-5 | |
| PV9; se a-POP | – | |||
| Pyrovaleron | P IV | 3563-49-3 | ||
| Racemetorfan (metorfan) | N I | 510-53-2 | ||
| Racemoramid (moramid) | N I | 545-59-5 | ||
| Racemorfan (morfanol) | N I | 297-90-5 | ||
| RCS-4 | 1345966-78-0 | |||
| RCS-4 4-hydroksyfenylmetabolitt | 1443988-18-8 | |||
| RCS-4-C4 homolog | 1345966-77-9 | |||
| RCS-8 | Forbudt etter § 5 | 1345970-42-4 | ||
| Remifentanil | N I | 132875-61-7 | ||
| Rolicyclidin (PCPy) | P I | Forbudt etter § 5 | 2201-39-0 | |
| Secbutabarbital (butabarbital) | P IV | 125-40-6 | ||
| Secobarbital | P II | 76-73-3 | ||
| Senecioylfentanyl (β-metyl krotonylfentanyl) | Forbudt etter § 5 | – | ||
| Sopper med innhold av psilocybin eller psilocin (herunder bl.a. soppsporer og dyrkede, tørkede eller på annen måte bearbeidede sopper) | Forbudt etter § 5 | |||
| Spiss fleinsopp; se Psilocybe semilanceata | ||||
| STP; se DOM | 15588-95-1 | |||
| Sufentanil | N I | 56030-54-7 | ||
| Syklobarbital | P III | 52-31-3 | ||
| Syklopentylfentanyl | Forbudt etter § 5 | 2088918-01-6 | ||
| Syklopropylfentanyl | N I | Forbudt etter § 5 | 1169-68-2 | |
| Tapentadol | 175591-23-8 | |||
| TCP; se tenocyclidin | 21500-98-1 | |||
| Tebain (paramorfin) | N I | 115-37-7 | ||
| Temazepam | P IV | 846-50-4 | ||
| Tenamfetamin (MDA) | P I | Forbudt etter § 5 | 4764-17-4 | |
| Tenocyclidin (TCP) | P I | Forbudt etter § 5 | 21500-98-1 | |
| Tetrahydrocannabinol | P II | Forbudt etter § 5 | 1972-08-3 | |
| Tetrahydrocannabinol – følgende regioisomere: | P I | Forbudt etter § 5 | ||
| delta-6a(7)-THC | 59042-44-3 | |||
| delta-6a(10a)-THC | 7663-50-5 | |||
| delta-7-THC | 42793-13-5 | |||
| delta-8-THC | 5957-75-5 | |||
| delta-9(11)-THC | 27179-28-8 | |||
| delta-10-THC | 7663-51-6 | |||
| Tetrahydrofuranylfentanyl | N I | Forbudt etter § 5 | 2142571-01-3 | |
| Tetrametylsyklopropanfentanyl (TMCPF) | Forbudt etter § 5 | – | ||
| Tetrazepam | P IV | 10379-14-3 | ||
| Thebacon | N I | 466-90-0 | ||
| TH-PHP | Forbudt etter § 5 | – | ||
| TH-PVP | Forbudt etter § 5 | 2304915-07-7 | ||
| Tilidin | N I | 51931-66-9 | ||
| Tiofentanyl | N I+IV | Forbudt etter § 5 | 1165-22-6 | |
| Tiopental | 76-75-5 | |||
| TMA (3,4,5-trimetoksyamfetamin) | P I | Forbudt etter § 5 | 1082-88-8 | |
| TMA-2 (2,4,5-trimetoksyamfetamin) | Forbudt etter § 5 | 1083-09-6 | ||
| TMA-3 (2,3,4-trimetoksyamfetamin) | Forbudt etter § 5 | 1082-23-1 | ||
| TMA-6 (2,4,6-trimetoksyamfetamin) | Forbudt etter § 5 | 15402-79-6 | ||
| Tramadol | 27203-92-5 | |||
| Trefentanil (A-3665) | Forbudt etter § 5 | 120656-74-8 | ||
| Triazolam | P IV | 28911-01-5 | ||
| Trimeperidin (promedol) | N I | 64-39-1 | ||
| U-47700 | N I | Forbudt etter § 5 | 121348-98-9 | |
| UR-144 | P II | Forbudt etter § 5 | 1199943-44-6 | |
| Valerylfentanyl | N I | Forbudt etter § 5 | 122882-90-0 | |
| Valmuehalm; se poppy straw | ||||
| Vinylbarbital (vinylbital) | P IV | 2430-49-1 | ||
| XLR-11 | P II | Forbudt etter § 5 | 1364933-54-9 | |
| Zipeprol | P II | Forbudt etter § 5 | 34758-83-3 | |
| Zolpidem | P IV | 82626-48-0 | ||
| Zopiklon | 43200-80-2 |
| 2-(4-Metylpiperazin-1-yl)-1-fenylpropan-1-on | 2-(4-metylpiperazin-1-yl)-1-fenyl-propan-1-on; 2-(4-metyl-1-piperazinyl)-1-fenyl-1-propanon; 2-(4-metylpiperazin-1-yl)-1-fenylpropan-1-on |
| 2,3-Dimetyletkatinon | 1-(2,3-dimetylfenyl)-2-(etylamino)propan-1-on |
| 2,3-DMMC | 2,3-dimetylmetkatinon |
| 2,3-MDMC | 1-(1,3-benzodioksol-4-yl)-2-(metylamino)propan-1-on |
| 2,4,5-TMMC | 2,4,5-trimetylmetkatinon |
| 2,4-DMMC | 2,4-dimetylmetkatinon |
| 2,4-DMPPP | 1-(2,4-dimetylfenyl)-2-pyrrolidin-1-yl-propan-1-on |
| 2,5-Dimetoksy-4-etyltioamfetamin | 1-[4-(etylsulfanyl)-2,5-dimetoksyfenyl] propan-2-amin; 4-(etyltio)-2,5-dimetoksy-α-metyl-benzenetanamin |
| 2,5-Dimetoksy-4-isopropylamfetamin | 1-[2,5-dimetoksy-(propan-2-yl)fenyl]propan-2-amin; 1-(2,5-dimetoksy-4-propan-2-ylfenyl)propan-2-amin |
| 2,5-Dimetoksyamfetamin | 1-(2,5-dimetoksyfenyl)propan-2-amin; 1-(2,5-dimetoksyfenyl)-2-aminopropan |
| 2,5-DMMA | 2,5-dimetoksy-N,α-dimetyl-benzenetanamin; 1-(2,5-dimetoksyfenyl)-N-metylpropan-2-amin |
| 2,6-Dibrom-meskalin | 2-(2,6-dibrom-3,4,5-trimetoksyfenyl)etanamin; 2,6-dibrom-3,4,5-trimetoksy-fenetylamin |
| 25N-NBOMe | 2,5-dimetoksy-N-[(2-metoksyfenyl)metyl]-4-nitro-benzenetanamin; 2-(2,5-dimetoksy-4-nitrofenyl)-N-[(2-metoksyfenyl)metyl]etan-1-amin; 2-(2,5-dimetoksy-4-nitrofenyl)-N-[(2-metoksyfenyl)metyl]etanamin |
| 2-Brom-meskalin | 2-(2-brom-3,4,5-trimetoksyfenyl)etanamin |
| 2C-B | 2,5-dimetoksy-4-bromfenetylamin |
| 2C-B-FLY | 8-brom-2,3,6,7-tetrahydro-benzo[1,2-b:4,5-b']difuran-4-etanamin |
| 2C-B-NBOMe | 2,5-dimetoksy-4-brom-N-(2-metoksybenzyl)fenetylamin |
| 2C-C | 2,5-dimetoksy-4-klorfenetylamin |
| 2C-C-NBOMe | 2,5-dimetoksy-4-klor-N-(2-metoksybenzyl)fenetylamin |
| 2C-D | 2,5-dimetoksy-4-metylfenetylamin |
| 2C-D-NBOMe | 2,5-dimetoksy-4-metyl-N-(2-metoksybenzyl)fenetylamin |
| 2C-E | 2,5-dimetoksy-4-etylfenetylamin |
| 2-CEC | 2-kloretkatinon |
| 2C-E-NBOMe | 2-(4-etyl-2,5-dimetoksyfenyl)-N-(2-metoksybenzyl)etanamin |
| 2C-F | 2,5-dimetoksy-4-fluorofenetylamin |
| 2C-G | 3,4-dimetyl-2,5-dimetoksyfenetylamin; 2-(2,5-dimetoksy-3,4-dimetylfenyl)etan-1-amin |
| 2C-G-NBOMe | 2,5-dimetoksy-3,4-dimetyl-N-(2-metoksybenzyl)fenetylamin |
| 2C-H | 2,5-dimetoksyfenetylamin |
| 2C-H-NBOMe | 2,5-dimetoksy-N-(2-metoksybenzyl)fenetylamin |
| 2C-I | 2,5-dimetoksy-4-jodfenetylamin |
| 2C-I-NBOMe | 2,5-dimetoksy-4-jod-N-(2-metoksybenzyl)fenetylamin |
| 2C-iP | 2-(2,5-dimetoksy-4-propan-2ylfenyl)etanamin; 2-[2,5-dimetoksy-4-(propan-2-yl)fenyl]etan-1-amin; 2-(4-isopropyl-2,5-dimetoksyfenyl)etan-1-amin; 4-isopropyl-2,5-dimetoksyfenetylamin |
| 2-Cl-4,5-MDMA | 2-klor-4,5-metylendioksymetamfetamin |
| 2-CMC | 2-klormetkatinon |
| 2C-P | 2,5-dimetoksy-4-propylfenetylamin |
| 2C-T-2 | 2,5-dimetoksy-4-etyltiofenetylamin |
| 2C-T-21 | 2-[4-(2-fluoretylsulfanyl)-2,5-dimetoksy-fenyl]etanamin; 2-{4-[(2-fluoretyl)sulfanyl]-2,5-dimetoksyfenyl}etan-1-amin; 4-(2-fluoretyltio)-2,5-dimetoksyfenetylamin |
| 2C-T-4 | 2,5-dimetoksy-4-isopropyltiofenetylamin |
| 2C-T-7 | 2,5-dimetoksy-4-propyltiofenetylamin |
| 2-EEC | 2-etyletkatinon |
| 2-EMC | 2-etylmetkatinon |
| 2-FA | 2-fluoramfetamin |
| 2-FEA | 2-fluoretamfetamin |
| 2-Fluordesklorketamin | 2-(2-fluorfenyl)-2-metylamino-sykloheksanon |
| 2-FMA | 2-fluormetamfetamin |
| 2-FMC | 2-fluormetkatinon |
| 2-Klor-N-etylamfetamin | 1-(2-klorfenyl)-N-etylpropan-2-amin |
| 2-MA | 2-metylamfetamin |
| 2-MEC | 2-metyl-N-etylkatinon |
| 2-Me-PVP | 1-(2-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on; 1-(2-metylfenyl)-2-pyrrolidin-1-ylpentan-1-on |
| 2-Metyl-AP-237 | 1-[2-metyl-4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on |
| 2-Metyletylbufedron | 2-(etylamino)-1-(2-metylfenyl)butan-1-on; 2-(etylamino)-1-(2-metylfenyl)-1-butanon |
| 2-Metylmetamfetamin | N-metyl-1-(2-metylfenyl)propan-2-amin; metyl[1-(2-metylfenyl)propan-2-yl]amin; n-metyl-1-(o-tolyl)propan-2-amin |
| 2-Metylmetoksyacetylfentanyl | 2-metoksy-N-(2-metylfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-acetamid |
| 2-Metyl-α-PiHP | 4-metyl-1-(2-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on; 4-metyl-2-(pyrrolidin-1-yl)-1-(o-tolyl)pentan-1-on |
| 2-MMA | 2-metoksymetamfetamin |
| 2-MMC | 2-metylmetkatinon |
| 3,4-DCEC | 3,4-dikloretkatinon |
| 3,4-Diklor-N,N-sykloheksylmetylmetkatinon | 2-(sykloheksyl(metyl)amino)-1-(3,4-diklorfenyl)propan-1-on |
| 3,4-Dimetyletkatinon | 1-(3,4-dimetylfenyl)-2-(etylamino)propan-1-on |
| 3,4-Dimetyl-α-PVP | 1-(3,4-dimetylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
| 3,4-DMA | 3,4-dimetoksyamfetamin |
| 3,4-DMMC | 3,4-dimetylmetkatinon |
| 3,4-EDMC | 3,4-etylendioksymetkatinon; 1-(2,3-dihydro-1,4-benzodioksin-6-yl)-2-(metylamino)-1-propanon |
| 3',4'-MDPBP | 3',4'-metylendioksy-α-pyrrolidinobutyrofenon |
| 3',4'-MDPHP | 3',4'-metylendioksy-α-pyrrolidinoheksiofenon |
| 3,4-Metylendioksy PV8, MDPEP | 1-(1,3-benzodioksol-5-yl)-2-(pyrrolidin-1-yl)heptan-1-on |
| 3,4-Metylendioksy-α-pyrrolidinoisoheksanofenon | 1-(1,3-benzodioksol-5-yl)-4-metyl-2-(1-pyrrolidinyl)-1-pentanon; 1-(1,3-benzodioksol-5-yl)-4-metyl-2-pyrrolidin-1-ylpentan-1-on |
| 3',4'-Tetrametylen-α-pyrrolidinobutiofenon | 2-(1-pyrrolidinyl)-1-(5,6,7,8-tetrahydro-2-naftalenyl)-1-butanon |
| 3-Allylfentanyl | N-[(3S,4R)-1-fenetyl-3-prop-2-enylpiperidin-4-yl]-N-fenylpropanamid |
| 3-BMC | 3-brommetkatinon |
| 3-CEC | 3-kloretkatinon |
| 3-CMC | 3-klormetkatinon |
| 3-EEC | 3-etyletkatinon |
| 3-EMC | 3-etylmetkatinon |
| 3-FA | 3-fluoramfetamin |
| 3-Fluorisobutyrfentanyl | N-(3-fluorfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-isobutanamid; N-(3-fluorfenyl)-2-metyl-N-[1-(2-fenyletyl)-4-piperidinyl]-propanamid |
| 3-Fluor-α-PPP | 3-fluor-α-pyrrolidinopropiofenon |
| 3-FMA | 3-fluormetamfetamin |
| 3-FMC | 3-fluormetkatinon |
| 3F-NEB | 2-(etylamino)-1-(3-fluorfenyl)butan-1-on |
| 3F-NEH | 2-(etylamino)-1-(3-fluorfenyl)heksan-1-on |
| 3F-PHP | 1-(3-fluorfenyl)-2-pyrrolidin-1-ylheksan-1-on |
| 3F-PiHP | 1-(3-fluorfenyl)-4-metyl-2-(pyrrolidin-1-yl)pentan-1-on |
| 3F-α-PVP | 3-fluor-α-pyrrolidinovalerofenon |
| 3-Klorkatinon | 2-amino-1-(3-klorfenyl)propan-1-on; 2-amino-1-(3-klorfenyl)-1-propanon |
| 3-Klor-N-etylamfetamin | 1-(3-klorfenyl)-N-etylpropan-2-amin |
| 3-MAM | 3-acetylmorfin |
| 3-MeA | 3-metylamfetamin |
| 3-MEC | 3-metyl-N-etylkatinon |
| 3-MeOMC | 3-metoksymetkatinon |
| 3-MeO-NBOMe | 2-(3-metoksyfenyl)-N-[(2-metoksyfenyl)metyl]etan-1-amin |
| 3'-Me-PVP | 1-(3-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
| 3-Metoksyamfetamin | 1-(3-metoksyfenyl)propan-2-amin |
| 3-Metylbutyrfentanyl | N-[3-metyl-1-(2-fenyletyl)piperidin-4-yl]-N-fenylbutanamid |
| 3-Metylflefedron | 3-metyl-4-fluormetkatinon |
| 3-Metyl-N-propyl-katinon | 2-(propylamino)-1-(3-metylfenyl)-1-propanon; 2-(propylamino)-1-(m-tolyl)propan-1-on |
| 3-Metyl-α-PHiP | 4-metyl-1-(3-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on; 4-metyl-2-(pyrrolidin-1-yl)-1-(m-tolyl)pentan-1-on |
| 3-MMC | 3-metylmetkatinon |
| 4,4'-DMAR | para-metyl-4-metylaminorex (4,4'-dimetylaminorex) |
| 4-AcO-DET | 4-acetoksy-N,N-dietyltryptamin |
| 4-AcO-DiPT | 4-acetoksy-N,N-diisopropyltryptamin |
| 4-AcO-DMT | 4-acetoksy-N,N-dimetyltryptamin |
| 4-AcO-EPT | [3-[2-[etyl(propyl)amino]etyl]-1H-indol-4-yl] acetat; 3-[2-(etylpropylamino)etyl]-1H-indol-4-ol, 4-acetat |
| 4-AcO-MET | 4-acetoksy-N-metyl-N-etyltryptamin |
| 4-AcO-MiPT | 4-acetoksy-N-metyl-N-isopropyltryptamin |
| 4-AcO-MPT | 3-[2-(metylpropylamino)etyl]-1H-indol-4-ol, 4-acetat |
| 4-BMC | 4-brommetkatinon |
| 4-Bromfentanyl | N-(4-bromfenyl)-N-[1-(2-fenyletyl)piperidin-4-yl]propanamid |
| 4Br-α-PPP | 4-brom-α-pyrrolidinopropiofenon |
| 4Br-α-PVP | 4-brom-α-pyrrolidinovalerofenon |
| 4-CA | 4-kloramfetamin |
| 4-CBC | 4-klor-N-butylkatinon |
| 4C-D | 1-(2,5-dimetoksy-4-metylfenyl)butan-2-amin |
| 4-CEC | 4-kloretkatinon |
| 4-CIC | 4-klorisopropylkatinon |
| 4-Cl-3-MMC | 1-(4-klor-3-metylfenyl)-2-(metylamino)propan-1-on |
| 4-CMA | 4-klormetamfetamin |
| 4-CMC | 4-klormetkatinon |
| 4-EEC | 4-etyletkatinon |
| 4-Etyl-α-PVP | 4-etyl-α-pyrrolidinopentiofenon |
| 4F-3-metyl-α-PHP | 1-(4-fluor-3-metylfenyl)-2-pyrrolidin-1-yl-heksan-1-on; 1-(4-fluor-3-metylfenyl)-2-(pyrrolidin-1-yl)heksan-1-on |
| 4-FEC | 4-fluoretkatinon |
| 4-Fenylfentanyl | N-fenyl-N-[4-fenyl-1-(2-fenyletyl)piperidin-4-yl]propanamid |
| 4-FIBF | 4-fluorisobutyrfentanyl |
| 4-Fluor-N-isopropylpentedron | 1-(4-fluorfenyl)-2-(1-metyletylamino)pentan-1-on |
| 4-Fluorpentedron | 4-fluor-α-metylaminovalerofenon |
| 4-FMA | 4-fluormetamfetamin |
| 4-FMC | 4-fluormetkatinon |
| 4F-MDMB-BINACA | metyl 2-(1-(4-fluorbutyl)-1H-indazol-3-karboksamido)-3,3-dimetylbutanoat |
| 4F-NEB | 4-fluor-N-etylbufedron, 2-(etylamino)-1-(4-fluorfenyl)butan-1-on |
| 4F-NEP | 4-fluor-N-etylpentedron |
| 4F-PBP | 4-fluor-α-pyrrolidinobutyrofenon |
| 4F-α-PHiP | 1-(4-fluorfenyl)-4-metyl-2-(pyrrolidin-1-yl)pentan-1-on |
| 4F-α-PHP | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)heksan-1-on, 4-fluor-α-pyrrolidinoheksanofenon |
| 4F-α-POP | 4-fluor-α-pyrrolidinooktafenon |
| 4F-α-PVP | 4-fluor-α-pyrrolidinovalerofenon |
| 4F-α-PVP piperidinanalog | 1-(4-fluorfenyl)-2-(piperidin-1-yl)pentan-1-on |
| 4-HO-DET | 4-hydroksy-N,N-dietyltryptamin |
| 4-HO-DPT | 3-[2-(dipropylamino)etyl]-1H-indol-4-ol |
| 4-HO-EPT | 3-{2-[etyl(propyl)amino]etyl}-1H-indol-4-ol |
| 4-HO-McPT | 3-{2-[syklopropyl(metyl)amino]etyl}-1H-indol-4-ol |
| 4-HO-MET | 4-hydroksy-N-metyl-N-etyltryptamin |
| 4-HO-MiPT | 4-hydroksy-N-metyl-N-isopropyltryptamin |
| 4-HO-MPT | 3-{2-[metyl(propyl)amino]etyl}-1H-indol-4-ol |
| 4-Hydroksy DiPT | 4-hydroksy-N,N-diisopropyltryptamin; 3-[2-(diisopropylamino)etyl]-1H-indol-4-ol |
| 4'-Hydroksynitazen | 4-[[1-[2-(dietylamino)etyl]-5-nitro-1H-benzimidazol-2-yl]metyl]-fenol |
| 4-Klor-N,N-DMC | 1-(4-klorfenyl)-2-(dimetylamino)-1-propanon |
| 4-Klor-N-etylamfetamin | 1-(4-klorfenyl)-N-etyl-2-propanamin; 1-(4-klorfenyl)-N-etylpropan-2-amin; 4-klor-N-etyl-α-metyl-benzenetanamin |
| 4-Klorpentedron | 4-klor-α-metylaminovalerofenon |
| 4-Klor-α-PHP | 1-(4-klorfenyl)-2-pyrrolidin-1-ylheksan-1-on |
| 4-Klor-α-PPP | 4-klor-α-pyrrolidinopropiofenon |
| 4-Klor-α-PVP | 4-klor-α-pyrrolidinovalerofenon |
| 4-MA | 4-metylamfetamin |
| 4-MBC | 4-metyl-N-benzylkatinon |
| 4-MC | 4-metylkatinon |
| 4-MEC | 4-metyl-N-etylkatinon |
| 4-MEC (4-metyletkatinon) | 2-(etylamino)-1-(4-metylfenyl)propan-1-on |
| 4-MeMABP | 4-metyl-a-metylaminobutyrofenon |
| 4-MeO-MiPT | N-[2-(4-metoksy-1H-indol-3-yl)etyl]-N-metylpropan-2-amin |
| 4-MeOPBP | 4'-metoksy-alfa-pyrrolidinobutiofenon |
| 4-MeO-α-PVP | 4-metoksy-α-pyrrolidinovalerofenon |
| 4-Metoksy PV8 | 1-(4-metoksyfenyl)-2-pyrrolidin-1-ylheptan-1-on |
| 4-Metoksy PV9 | 1-(4-metoksyfenyl)-2-pyrrolidin-1-yloktan-1-on |
| 4'-Metylheksedron | 2-(metylamino)-1-(4-metylfenyl)-1-heksanon; 2-(metylamino)-1-(4-metylfenyl)heksan-1-on |
| 4'-Metyl-N-isopropylpentedron | 2-((1-metyletyl)amino)-1-(4-metylfenyl)-1-pentanon; 1-(4-metylfenyl)-2-(propan-2-ylamino)pentan-1-on |
| 4'-Metyl-α-PiHP | 4-metyl-2-pyrrolidin-1-yl-1-(4-metylfenyl)pentan-1-on; 4-metyl-1-(4-metylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
| 4'-Metyl-α-pyrrolidinobutiofenon | (RS)-1-(4-metylfenyl)-2-(1-pyrrolidinyl)-1-butanon |
| 4-MMA | 4-metylmetamfetamin |
| 4-MPD | 4-metylpentedron |
| 4-MTA | 4-metyltioamfetamin |
| 4-Propoksy-3,5-DMPEA | 4-propoksy-3,5-dimetoksyfenetylamin |
| 5-AcO-DET | 5-acetoksy-N,N-dietyltryptamin; 3-(2-dietylaminoetyl)-1H-indol-5-yl acetat |
| 5-DBFPV | 5-dihydrobenzofuranpyrovaleron |
| 5F-AMB-PINACA | metyl (1-(5-fluorpentyl)-1H-indazole-3-karbonyl)valinat |
| 5F-APINACA (5F-AKB-48) | N-(adamantan-1-yl)-1-((5-fluorpentyl)-1H-indazol-3-karboksamid |
| 5F-JWH-398 | (4-klornaftalen-1-yl)-[1-(5-fluorpentyl)indol-3-yl]metanon |
| 5F-MDMB-PICA | metyl 2-(1-(5-fluorpentyl)-1H-indole-3-karboksamido)-3,3-dimetylbutanoat |
| 5F-MDMB-PINACA | metyl-2-{[1-(5-fluorpentyl)-1H-indazol-3-karbonyl]amino}-3,3-dimetylbutanoat |
| 5F-PB-22 | quinolin-8-yl 1-(5-fluorpentyl)-1H-indol-3-karboksylat |
| 5-IT | 5-(2-aminopropyl)indol |
| 5-MAPDB | 1-(2,3-dihydrobenzofuran-5-yl)-N-metylpropan-2-amin |
| 5-MAPDI | 1-(2,3-dihydro-1H-inden-5-yl)-N-metylpropan-2-amin |
| 5-MeO-DBT | N-butyl-N-[2-(5-metoksy-1H-indol-3-yl)etyl]butan-1-amin |
| 5-MeO-DiPT | 5-metoksy-N,N-diisopropyltryptamin |
| 5-MeO-DMT | 5-metoksy-N,N-dimetyltryptamin |
| 5-MeO-EiPT | 5-metoksy-N-etyl-N-isopropyltryptamin |
| 5-MeO-MET | 5-metoksy-N-metyl-N-etyltryptamin |
| 5-MeO-MiPT | 5-metoksy-N-metyl-N-isopropyltryptamin |
| 6-AcO-DET | 6-acetoksy-N,N-dietyltryptamin; 3-(2-dietylaminoetyl)-1H-indol-6-yl acetat |
| 6-MAM | 6-acetylmorfin |
| 6-Metoksy-MDA | 6-metoksy-3,4-metylendioksyamfetamin |
| 6-Nikotinoylmorfin | (4R,4aR,7S,7aR,12bS)-9-hydroksy-3-metyl-2,3,4,4a,7,7a-heksahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-7-yl nikotinat; [(4R,4aR,7S,7aR,12bS)-9-hydroksy-3-metyl-2,4,4a,7,7a,13-heksahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-7-yl] pyridin-3-karboksylat |
| 7-AcO-DET | 7-acetoksy-N,N-dietyltryptamin; 3-(2-dietylaminoetyl)-1H-indol-7-yl acetat |
| 7-hydroksymitragynin (7-HMG) | 7α-hydroksy-7H-mitragynin |
| α-EPP | α-etylaminopentiofenon |
| α-Metyl butyryl fentanyl | 2-metyl-N-fenyl-N-[1-(2-fenyletyl)-4-piperidinyl]-butanamid |
| α-PBP | α-pyrrolidinobutiofenon |
| α-PEP | α-pyrrolidinoenantofenon |
| α-PHP | α-pyrrolidinoheksanofenon |
| α-PHPP | α-pyrrolidinoheptofenon |
| α-PiHP | 4-metyl-1-fenyl-2-(pyrrolidin-1-yl)pentan-1-on |
| α-PNP | 1-fenyl-2-(pyrrolidin-1-yl)nonan-1-on |
| α-POP | a-pyrrolidinooktafenon |
| α-PPP | α-pyrrolidinopropiofenon |
| α-PVP | α-pyrrolidinovalerofenon |
| α-TMT | α-N,N-trimetyltryptamin |
| AB-CHMINACA | N-[1-amino-3-metyl-1-oksobutan-2-yl]-1-(sykloheksylmetyl)-1H-indazol-3-karboksamid |
| AB-FUBINACA | (S)-N-(1-amino-3-metyl-1-oksobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboksamid |
| AB-PINACA | N-[1-amino-3-metyl-1-oksobutan-2-yl]-1-pentyl-1H-indazol-3-karboksamid |
| ADB-BUTINACA | N-(1-amino-3,3-dimetyl-1-oksobutan-2-yl)-1-butyl-1H-indazol-3-karboksamid |
| ADB-CHMINACA | N-(1-amino-3,3-dimetyl-1-oksobutan-2-yl)-1-(sykloheksylmetyl)-1H-indazol-3-karboksamid |
| ADB-FUBINACA | N-(1-amino-3,3-dimetyl-1-oksobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboksamid |
| AH-7921 | 3,4-diklor-N-((1-(dimetylamino)sykloheksyl)metyl)benzamid |
| Allyleskalin | 3,5-dimetoksy-4-(allyloksy)fenetylamin |
| AM-2201 | (1-(5-fluorpentyl)-1H-indol-3-yl)(naftalen-1-yl)metanon |
| AM-2201 2-hydroksyindol metabolitt | (1-(5-fluorpentyl)-2-hydroksy-1H-indol-3-yl)(naftalen-1-yl)metanon |
| AM-2201 5-hydroksyindol metabolitt | (1-(5-fluorpentyl)-5-hydroksy-1H-indol-3-yl)(naftalen-1-yl)metanon |
| AM-2201 6-hydroksyindol metabolitt | (1-(5-fluorpentyl)-6-hydroksy-1H-indol-3-yl)(naftalen-1-yl)metanon |
| AM-2201 7-hydroksyindol metabolitt | [1-(5-fluorpentyl)-7-hydroksy-1H-indol-3-yl](1-naftyl)metanon; [1-(5-fluorpentyl)-7-hydroksyindol-3-yl]-naftalen-1-ylmetanon; [1-(5-fluorpentyl)-7-hydroksyindol-3-yl]-naftalen-1-ylmetanon |
| AM-2201 kloranalog | (1-(5-klorpentyl)-1H-indol-3-yl)(naftalen-1-yl)metanon |
| AM-679 | (1-pentyl-1H-indol-3-yl)(2-jodfenyl)metanon |
| AM-694 | (1-(5-fluorpentyl)-1H-indol-3-yl)(2-jodfenyl)metanon |
| Amineptin | 7-((10,11-dihydro-5H-dibenzo[a,d]-syklohepten-5-yl)amino)heptansyre |
| β-metylfentanyl | N-fenyl-N-[1-(2-fenylpropyl)piperidin-4-yl]propanamid |
| BDB | 1,3-benzodioksolylbutanamin |
| bk-3,4-MDPA | β-keto-3,4-metylenedioksypropylamfetamin |
| bk-6-metoksy-MDMA | β-keto-6-metoksy-3,4-metylendioksymetamfetamin |
| bk-DMBDB | β-keto-dimetylbenzodioksolylbutanamin |
| bk-EBDB | β-keto-N-etyl-1,3-benzodioksolylbutanamin |
| bk-IMP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(metylamino)propan-1-on |
| bk-IVP | 1-(2,3-dihydro-1-inden-5-yl)-2-(etylamino)pentan-1-on |
| bk-MBDB | β-keto-metylbenzodioksolylbutanamin |
| bk-MDDMA | β-keto-3,4-metylendioksydimetylamfetamin |
| bk-MDEA | β-keto-metylendioksy-N-etylamfetamin |
| bk-MDMA | β-keto-3,4-metylendioksymetamfetamin |
| bk-MMDMA | β-keto-5-metoksy-3,4-metylendioksymetamfetamin |
| bk-PBDB | β-keto-N-propylbenzodioksolylbutanamin |
| bk-PMMA | β-keto-para-metoksymetamfetamin |
| BMDB | 2-benzylamino-1-(3,4-metylendioksyfenyl)butan-1-on |
| BMDP | 3,4-metylendioksy-N-benzylkatinon |
| Brifentanil | N-[(3R,4S)-1-[2-(4-etyl-5-oksotetrazol-1-yl)etyl] -3-metylpiperidin-4-yl]-N-(2-fluorfenyl)-2-metoksyacetamid; N-[1-[2-(4-etyl-5-oksotetrazol-1-yl)etyl]-3-metylpiperidin-4-yl]-N-(2-fluorfenyl)-2-metoksyacetamid |
| Bromazolam | 8-brom-6-fenyl-1-metyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin |
| Brorfin | 1-[1-[1-(4-bromofenyl)etyl]-piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-on |
| Butonitazen | 2-[(4-butoksyfenyl)metyl]-5-nitro-1-(2-pyrrolidin-1-yletyl)benzimidazol |
| Codeine Impurity D (EP) | (4R,4aR,7S,7aR,12bS)-10-[[(4R,4aR,7S,7aR,12bS)-7-hydroksy-3-metyl-2,4,4a,7,7a,13-heksahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-9-yl]oksy]-9-metoksy-3-metyl-2,4,4a,7,7a,13-heksahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-7-ol; 4,5α-epoksy-2-[(4,5α-epoksy-6α-hydroksy-17-metyl-7,8-didehydromorfinan-3-yl)oksy]-3-metoksy-17-metyl-7,8-didehydromorfinan-6α-ol |
| CP 47,497 | cannabisykloheksanol |
| CP 55,940 | 2-(5-hydroksy-2-(3-hydroksypropyl)-sykloheksyl)-5-(2-metyloktan-2-yl)fenol |
| CP-47,497-C8-homolog | 2-(3-hydroksysykloheksyl)-5-(2-metylnonan-2-yl)fenol |
| CUMYL-4CN-BINACA | 1-(4-cyanobutyl)-N-(1-metyl-1-fenyl-etyl)indazol-3-karboksamid |
| CUMYL-PEGACLONE | 2-(1-metyl-1-fenyl-etyl)-5-pentyl-pyrido[4,3-b]indol-1-on |
| delta-6a(7)-THC | (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimetyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol |
| delta-6a(10a)-THC | 7,8,9,10-tetrahydro-6,6,9-trimetyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| delta-7-THC | (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimetyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol |
| delta-8-THC | (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimetyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol |
| delta8-THC acetat | 6aR,7,10,10aR-tetrahydro-6,6,9-trimetyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, 1-acetat |
| delta-9-THC | (6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9- trimetyl-3-pentyl-6H-dibenzo[b,d]pyran1-ol |
| delta9-THC acetat | 6aR,7,8,10aR-tetrahydro-6,6,9-trimetyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, 1-acetat; (6aR,10aR)-6,6,9-trimetyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-yl acetat |
| delta-9(11)-THC | (6aR,10aR)-6a,7,8,9,10,10a-heksahydro-6,6-dimetyl-9-metylen-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| delta-10-THC | 6a,7,8,9-tetrahydro-6,6,9-trimetyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| DET | N,N-dietyltryptamin |
| DiPT | N,N-diisopropyltryptamin |
| DL-4662 | 1-(3,4-dimetoksyfenyl)-2-(etylamino)pentan-1-on |
| DMA | 2,5-dimetoksyamfetamin |
| DMHP | dimetylheptylpyran |
| DMT | N,N-dimetyltryptamin |
| DOB | 2,5-dimetoksy-4-bromamfetamin |
| DOC | 2,5-dimetoksy-4-kloramfetamin |
| DOET | 2,5-dimetoksy-4-etylamfetamin |
| DOI | 2,5-dimetoksy-4-jodamfetamin |
| DOM/STP | 2,5-dimetoksy-4-metylamfetamin |
| DOPR | 2,5-dimetoksy-4-propylamfetamin |
| DOT | 2,5-dimetoksy-4-metyltioamfetamin |
| DPT | N,N-dipropyltryptamin |
| EAM-2201 | (1-(5-fluorpentyl)-1H-indol-3-yl)(4-etyl-1-naftalenyl)-metanon |
| Eskalin | 3,5-dimetoksy-4-etoksyfenetylamin |
| Etometazen | 2-[2-(4-etoksybenzyl)-5-metyl-1H-benzo[d]imidazol-1-yl]-N,N-dietyletanamin; 2-[(4-etoksyfenyl)metyl]-N,N-dietyl-5-metyl-1H-benzimidazol-1-etanamin |
| Etonitazepipne | 2-[(4-etoksyfenyl)metyl]-5-nitro-1-(2-piperidin-1-yletyl)benzimidazol |
| Etyl morfin 6-β-D-glukuronid | (2S,3S,4S,5R,6R)-6-(((4R,4aR,7S,7aR,12bS)-9-etoksy-3-metyl-2,3,4,4a,7,7a-heksahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-7-yl)oksy)-3,4,5-trihydroksytetrahydro-2H-pyran-2-karboksylsyre |
| Etylpropyltryptamin | N-etyl-N-propyl-1H-indol-3-etanamin; N-etyl-N-[2-(1H-indol-3-yl)etyl]propan-1-amin |
| Fenaridin | N-[2,5-dimetyl-1-(2-fenyletyl)piperidin-4-yl]-N-fenylpropanamid; N-[2,5-dimetyl-1-(2-fenyletyl)-4-piperidinyl]-N-fenylpropanamid |
| Fenibut (Phenibut) | 4-amino-3-fenylbutansyre |
| Flunitazen | N,N-dietyl-2-[2-[(4-fluorfenyl)metyl]-5-nitrobenzimidazol-1-yl]etanamin |
| FUB-AMB | metyl (1-(4-fluorbenzyl)-1H-indazol-3-karbonyl)valinat |
| GHB | γ-hydroksybutyrat |
| Hexahydrocannabinol | (6aR,10aR)-6,6,9-trimetyl-3-pentyl-6a,7,8,9,10,10a-heksahydrobenzo[c]chromen-1-ol |
| Iso-butonitazen | N,N-dietyl-2-(2-(4-isobutoksybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)etan-1-amin |
| Isobutyrylfentanyl | 2-metyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid |
| Isoheksedron | 4-metyl-2-(metylamino)-1-fenylpentan-1-on |
| Isoheksylon | 4,N-dimetylpentylon; 1-(1,3-benzodioksol-5-yl)-(etylamino)heksan-1-on; 1-(benzo[d][1,3]dioksol-5-yl)-4-metyl-2-(metylamino)pentan-1-on |
| JWH-007 | (2-metyl-1-pentyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-011 | (1-(heptan-2-yl)-2-metyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-015 | (2-metyl-1-propyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-016 | (1-butyl-2-metyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-018 | naftalen-1-yl(1-pentyl-1H-indol-3-yl)metanon |
| JWH-018 2-hydroksyindol metabolitt | (2-hydroksy-1-pentyl-1H-indol-3-yl)(naftalen-1-yl)metanon; (2-hydroksy-1-pentylindol-3-yl)-naftalen-1-ylmetanon |
| JWH-019 | (1-heksyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-020 | (1-heptyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-022 | naftalen-1-yl(1-(pent-4-en-1-yl)-1H-indol-3-yl)metanon |
| JWH-030 | naftalen-1-yl(1-pentyl-1H-pyrrol-3-yl)metanon |
| JWH-031 | (1-heksyl-1H-pyrrol-3-yl)(naftalen-1-yl)metanon |
| JWH-047 | (1-butyl-2-metyl-1H-indol-3-yl)(7-metylnaftalen-1-yl)metanon |
| JWH-048 | (2-metyl-1-pentyl-1H-indol-3-yl)(7-metylnaftalen-1-yl)metanon |
| JWH-071 | (1-etyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-072 | naftalen-1-yl(1-propyl-1H-indol-3-yl)metanon |
| JWH-073 | (1-butyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-081 | (4-metoksynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| JWH-098 | (4-metoksynaftalen-1-yl)(2-metyl-1-pentyl-1H-indol-3-yl)metanon |
| JWH-116 | (2-etyl-1-pentyl-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-120 | (4-metylnaftalen-1-yl)(1-propyl-1H-indol-3-yl)metanon |
| JWH-122 | (4-metylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| JWH-122N-(4-pentenyl) analog | (4-metylnaftalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-yl)metanon |
| JWH-145 | naftalen-1-yl(1-pentyl-5-fenyl-1H-pyrrol-3-yl)metanon |
| JWH-147 | (1-heksyl-5-fenyl-1H-pyrrol-3-yl)(naftalen-1-yl)metanon |
| JWH-148 | (2-metyl-1-propyl-1H-indol-3-yl)(4-metylnaftalen-1-yl)metanon |
| JWH-149 | (2-metyl-1-pentyl-1H-indol-3-yl)(4-metylnaftalen-1-yl)metanon |
| JWH-164 | (7-metoksynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| JWH-166 | (6-metoksynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| JWH-167 | 1-(1-pentyl-1H-indol-3-yl)-2-fenyletan-1-on |
| JWH-171 | (Z)-1-((3-pentyl-1H-inden-1-yliden)metyl)naftalen |
| JWH-175 | 3-(naftalen-1-ylmetyl)-1-pentyl-1H-indol |
| JWH-176 | (E)-1-((3-pentyl-1H-inden-1-yliden)metyl)naftalen |
| JWH-180 | (1-propyl-1H-indol-3-yl)(4-propylnaftalen-1-yl)metanon |
| JWH-181 | (2-metyl-1-pentyl-1H-indol-3-yl)(4-propylnaftalen-1-yl)metanon |
| JWH-182 | (1-pentyl-1H-indol-3-yl)(4-propylnaftalen-1-yl)metanon |
| JWH-184 | 3-((4-metylnaftalen-1-yl)metyl)-1-pentyl-1H-indol |
| JWH-185 | 3-((4-metoksynaftalen-1-yl)metyl)-1-pentyl-1H-indol |
| JWH-192 | 4-(2-(3-((4-metylnaftalen-1-yl)metyl)-1H-indol-1-yl)etyl)morfolin |
| JWH-193 | (4-metylnaftalen-1-yl)(1-(2-morfolinoetyl)-1H-indol-3-yl)metanon |
| JWH-194 | 2-metyl-3-((4-metylnaftalen-1-yl)metyl)-1-pentyl-1H-indol |
| JWH-195 | 4-(2-(3-(naftalen-1-ylmetyl)-1H-indol-1-yl)etyl)morfolin |
| JWH-196 | 2-metyl-3-(naftalen-1-ylmetyl)-1-pentyl-1H-indol |
| JWH-197 | 3-((4-metoksynaftalen-1-yl)metyl)-2-metyl-1-pentyl-1H-indol |
| JWH-198 | (4-metoksynaftalen-1-yl)(1-(2-morfolinoetyl)-1H-indol-3-yl)metanon |
| JWH-199 | 4-(2-(3-((4-metoksynaftalen-1-yl)metyl)-1H-indol-1-yl)etyl)morfolin |
| JWH-200 | (1-(2-morfolinoetyl)-1H-indol-3-yl)(naftalen-1-yl)metanon |
| JWH-201 | 2-(4-metoksyfenyl)-1-(1-pentyl-1H-indol-3-yl)etan-1-on |
| JWH-203 | 2-(2-klorfenyl)-1-(1-pentyl-1H-indol-3-yl)etan-1-on |
| JWH-205 | 1-(2-metyl-1-pentyl-1H-indol-3-yl)-2-fenyletan-1-on |
| JWH-210 | (4-etylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| JWH-250 | 2-(2-metoksyfenyl)-1-(1-pentyl-1H-indol-3-yl)etan-1-on |
| JWH-251 | 1-(1-pentyl-1H-indol-3-yl)-2-(o-tolyl)etan-1-on |
| JWH-302 | 1-pentyl-3-(3-metoksyfenylacetyl)indol; 2-(3-metoksyfenyl)-1-(1-pentylindol-3-yl)etanon |
| JWH-307 | (5-(2-fluorfenyl)-1-pentylpyrrol-3-yl)-naftalen-1-ylmetanon |
| JWH-308 | naftalen-1-yl(5-(4-fluorfenyl)-1-pentyl-1H-pyrrol-3-yl)metanon |
| JWH-309 | 1-naftalenyl[5-(1-naftalenyl)-1-pentyl-1H-pyrrol-3-yl]-metanon |
| JWH-368 | naftalen-1-yl(5-(3-fluorfenyl)-1-pentyl-1H-pyrrol-3-yl)metanon |
| JWH-369 | [5-(2-klorfenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naftalenyl-metanon |
| JWH-398 | (4-klornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)metanon |
| Karisoprodol | N-isopropyl-2-metyl-2-propyl-1,3-propandiol dikarbamat; (RS)-2-{[(aminokarbonyl)oksy]metyl}-2-metylpentyl isopropylkarbamat |
| Ketamin | 2-(2-klorfenyl)-2-(metylamino)sykloheksan-1-on |
| Lofentanil | metyl (3S,4R)-3-metyl-1-(2-fenyletyl)-4-[fenyl(propionyl)amino]piperidin-4-karboksylat |
| MABP | α-metylaminobutyrofenon |
| MAL | 3,5-dimetoksy-4-(metylallyloksy)fenetylamin |
| MAM-2201 | (1-(5-fluorpentyl)-1H-indol-3-yl)(4-metylnaftalen-1-yl)metanon |
| MAM-2201 kloranalog | (1-(5-klorpentyl)-1H-indol-3-yl)(4-metylnaftalen-1-yl)metanon |
| MBDB | metylbenzodioksolylbutanamin |
| MDA | 3,4-metylendioksyamfetamin |
| MDMA | 3,4-metylendioksymetamfetamin |
| MDMB-4en-PINACA | metyl 3,3-dimetyl-2-(1-(pent-4-en-1-yl)-1H-indazol-3-karboksamido)butanoat |
| MDMB-CHMICA | metyl N-{[1-(sykloheksylmetyl)-1H-indol-3-yl]karbonyl}-3-metyl-L-valinat |
| MDMB-FUBINACA | metyl (2S)-2-{[1-(4-fluorobenzyl)indazol-3-karbonyl]amino}-3,3-dimethylbutanoate |
| MDPPP | 3,4-metylendioksy-α-pyrrolidinopropiofenon |
| MDPT(tBuONE) | 3,4-metylendioksy-N-tert-butylkatinon |
| MDPV | 3,4-metylendioksypyrovaleron |
| Menitazen | N,N-dietyl-2-[(4-metylfenyl)metyl]-5-nitro-1H-benzimidazol-1-etanamin; N,N-dietyl-2-[2-[(4-metylfenyl)metyl]-5-nitrobenzimidazol-1-yl]etanamin |
| MET | N-metyl-N-etyltryptamin |
| Metafedrin | N-metyl-1-(3-metylfenyl)propan-2-amin |
| Metamfepramon | 2-(dimetylamino)-1-fenyl-1-propanon; (RS)-2-dimetylamino-1-fenylpropan-1-on |
| Metodesnitazen | N,N-dietyl-2-[2-[(4-metoksyfenyl)metyl]benzimidazol-1-yl]etanamin |
| Metonitazen | N,N-dietyl-2-(2-(4-metoksybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)etan-1-amin |
| Metylendioksykatinon | (±)-2-amino-1-(3,4-metylendioksyfenyl)propan-1-on |
| MFPVP | 1-(3-metyl-4-fluorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
| Mitragynin | metyl (16E)-9,17-dimetoksy-16,17-didehydro-2 0β-corynan-16-karboksylat |
| MMDA | 5-metoksy-3,4-metylendioksyamfetamin |
| MOPPP | 4'-metoksy-alfa-pyrrolidinoproiofenon |
| MPA (metiopropamin) | N-metyl-1-(tiofen-2-yl)propan-2-amin |
| MPHP | 4-metylfenylpyrrolidinylheksanon |
| MPPP | 4'-metyl-alfa-pyrrolidinopropiofenon |
| MPPP | 1-metyl-4-fenylpiperidin-4-yl propionat |
| MT-45 | 1-sykloheksyl-4-(1,2-difenyletyl)piperazin |
| N,N-dietylheksedron | 2-(dietylamino)-1-fenylheksan-1-on; 2-(dietylamino)-1-fenyl-heksan-1-on |
| N,N-dietylpentylon | 1-(1,3-benzodioksol-5-yl)-2-(dietylamino)pentan-1-on; 1-(1,3-benzodioksol-5-yl)-2-(dietylamino)-1-pentanon |
| N-butyl bufedron | 2-(butylamino)-1-fenylbutan-1-on |
| N-butylbutylon | 1-(2H-1,3-benzodioksol-5-yl)-2-(butylamino)butan-1-on; 1-(benzo[d][1,3]dioksol-5-yl)-2-(butylamino)butan-1-on |
| N-Butylheksedron | 2-(butylamino)-1-fenyl-1-heksanon |
| N-butyl-N-metyl butylon | 1-(benzo[d][1,3]dioksol-5-yl)-2-(butyl(metyl)amino)butan-1-on |
| N-butylpentylon | 1-(1,3-benzodioksol-5-yl)-2-(butylamino)pentan-1-on; 1-(2H-1,3-benzodioksol-5-yl)-2-(butylamino)pentan-1-on |
| N-desetyl etonitazen | 2-[(4-etoksyfenyl)metyl]-N-etyl-5-nitro-1H-benzimidazol-1-etanamin; 2-[2-(4-etoksybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl]-N-etyletanamin; 2-[2-[(4-etoksyfenyl)metyl]-5-nitrobenzimidazol-1-yl]-N-etyletanamin |
| N-desetylisotonitazen | N-etyl-2-[[4-(1-metyletoksy)fenyl]metyl]-5-nitro-1H-benzimidazol-1-etanamin; N-etyl-2-[5-nitro-2-[(4-propoksyfenyl)metyl]benzimidazol-1-yl]etanamin |
| NEB | N-etylbufedron |
| N-etyl 2C-B | 2-(4-brom-2,5-dimetoksyfenyl)-N-etyletanamin |
| N-etylheksedron | 2-(etylamino)-1-fenylheksan-1-on |
| N-Etylheksylon | 1-(1,3-benzodioksol-5-yl)-(etylamino)heksan-1-on |
| N-etylheptylon | 3,4-metylendioksy-α-etylheptanofenon; 1-(1,3-benzodioksol-5-yl)-2-(etylamino)heptan-1-on |
| N-etylisoheksedron | 2-(etylamino)-4-metyl-1-fenyl-pentan-1-on |
| N-etyl-N-metyl butylon | 1-(benzo[d][1,3]dioksol-5-yl)-2-(etyl(metyl)amino)butan-1-on |
| N-etylpentylon | 1-(1,3-benzodioksol-5-yl)-2-(etylamino)-1-pentanon |
| N-isobutylheksedron | 2-[(2-metylpropyl)amino]-1-fenylheksan-1-on; 2-(isobutylamino)-1-fenylheksan-1-on |
| N-Me-2C-B | N-metyl-2,5-dimetoksy-4-bromfenetylamin |
| N-Me-2C-H | 2,5-dimetoksy-N-metylfenetylamin |
| N-metyletylon | 1-(1,3-benzodioksol-5-yl)-2-(etylmetylamino)-1-propanon; 1-(1,3-benzodioksol-5-yl)-2-[etyl(metyl)amino]propan-1-on |
| N-metyl-N-propyl metylon | 1-(benzo[d][1,3]dioksol-5-yl)-2-(metyl(propyl)amino)propan-1-on |
| NMT | N-metyltryptamin |
| Norkodein-6-glukuronid | (2S,3S,4S,5R,6R)-6-[[(4R,4aR,7S,7aR,12bS)-9-metoksy-1,2,3,4,4a,7,7a,13-oktahydro-4,12-metanobenzofuro[3,2-e]isoquinolin-7-yl]oksy]-3,4,5-trihydroksyoksan-2-karboksylsyre |
| N-pentylmetylon | 1-(benzo[d][1,3]dioksol-5-yl)2-pentylamino)propan-1-on; 1-(1,3-benzodioksol-5-yl)-2-(pentylamino)propan-1-on |
| N-propyl bufedron | 1-fenyl-2-(propylamino)-1-butanon |
| N-propyl-N-metyl butylon | 1-(benzo[d][1,3]dioksol-5-yl)-2-(metyl(propyl)amino)propan-1-on |
| N-propylnorpentedron | 1-fenyl-2-(propylamino)pentan-1-on |
| N-pyrrolidino metonitazen | 2-(4-metoksybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)etyl-1H-benzo[d]imidazol |
| N-sec-butyl pentedron | 2-[(butan-2-yl)amino]-1-fenylpentan-1-on; 2-[(1-metylpropyl)amino]-1-fenyl-1-pentanon |
| Oksymorfon-3-β-D-glukuronid | (2S,3S,4S,5R,6S)-3,4,5-trihydroksy-6-(((4R,4aS,7aR,12bS)-4a-hydroksy-3-metyl-7-okso-2,3,4,4a,5,6,7,7a-oktahydro-1H-4,12-metanobenzofuro[3,2-e]isoquinolin-9-yl)oksy)tetrahydro-2H-pyran-2-karboksylsyre |
| Orto-fluorfuranylfentanyl | N-(2-fluorfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-2-furankarboksamid |
| Para-bromamfetamin | 1-(4-bromfenyl)propan-2-amin |
| Para-fluorfuranylfentanyl | N-(4-fluorfenyl)-N-[1-(2-fenyletyl)piperidin-4-yl]furan-2-karboksamid |
| Para-klor metoksyacetyl fentanyl | N-(4-klorfenyl)-2-metoksy-N-[1-(2-fenyletyl)-4-piperidinyl]-acetamid |
| Para-klorfentanyl | N-(4-klorfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-propanamid |
| Para-metoksy metoksyacetyl fentanyl | 2-metoksy-N-(4-metoksyfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-acetamid |
| Para-metylsyklopropylfentanyl | N-(4-metylfenyl)-N-[1-(2-fenyletyl)-4-piperidinyl]-syklopropankarboksamid |
| PCE | N-etyl-1-fenylsykloheksanamin |
| PCPy | 1-(1-fenylsykloheksyl)pyrrolidin |
| Pentedron | α-metylaminovalerofenon |
| Pentylon | 1-(1,3-benzodioksol-5-yl)-2-(metylamino)-2-pentanon |
| PEPAP | 1-fenetyl-4-fenylpiperidin-4-yl acetat |
| PMA | para-metoksyamfetamin |
| Propylkatinon | 1-fenyl-2-(propylamino)-1-propanon; 1-fenyl-2-(propylamino)propan-1-on |
| Propylnitazen | N,N-dietyl-2-(5-nitro-2-(4-propylbenzyl)-1H-benzo[d]imidazol-1-yl)etan-1-amin; N,N-dietyl-2-[5-nitro-2-[(4-propylfenyl)metyl]benzimidazol-1-yl]etanamin |
| Protonitazepyn | 5-nitro-2-(4-propoksybenzyl)-1-(2-(pyrrolidin-1-yl)etyl)-1H-benzo[d]imidazol |
| Psilocin-O-glukuronid | (2S,3S,4S,5R,6S)-6-((3-(2-(dimetylamino)etyl)-1H-indol-4-yl)oksy)-3,4,5-trihydroksytetrahydro-2H-pyran-2-karboksylsyre |
| RCS-4 | (4-metoksyfenyl)(1-pentyl-1H-indol-3-yl)metanon |
| RCS-4 4-hydroksyfenylanalog | (4-hydroksyfenyl)(1-pentyl-1H-indol-3-yl)metanon |
| RCS-4-C4 | (1-butyl-1H-indol-3-yl)(4-metoksyfenyl)metanon |
| RCS-8 | 2-(2-metoksyfenyl)-1-[1-(2-sykloheksyletyl)indol-3-yl]etanon |
| TCP | 1-(1-(2-tienyl)sykloheksyl)piperidin |
| TH-PHP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)heksan-1-on |
| TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on |
| TMA | 3,4,5-trimetoksyamfetamin |
| TMA-2 | 2,4,5-trimetoksyamfetamin |
| TMA-3 | 1-(2,3,4-trimetoksyfenyl)propan-2-amin |
| TMA-6 | 2,4,6-trimetoksyamfetamin |
| Trefentanil | N-{1-[2-(4-etyl-5-okso-4,5-dihydro-1H-tetrazol-1-yl)etyl]-4-fenylpiperidin-4-yl}-N-(2-fluorfenyl)propanamid |
| U-47700 | 3,4-dikloro-N-(2-dimetylamino-sykloheksyl)-N-metyl-benzamid |
| UR-144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetrametylsyklopropyl)metanon |
| XLR-11 | [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetrametylsyklopropyl)metanon |
| Zopiklon | [6-(5-klor-2-pyridinyl)-5-okso-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-metylpiperazin-1-karboksylat |












32 endringer siden 2001
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Forskrift om endring i forskrifter på helseområdet (organisatoriske endringer i sentral helseforvaltning)
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i legemiddelforskriften og narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Endr. i narkotikaforskriften
Kilde: Norsk Lovtidend via Lovdata (api.lovdata.no)
§ 5
Forbudt narkotika, særlige kontrolltiltak
§ 6
Industriell bruk
§ 7
Tilvirkning
§ 8
Transport, lagring og håndtering
§ 9
Innførsel og utførsel
§ 10
Unntak fra krav om inn- og utførselssertifikat
§ 11
Transitt
§ 12
Virksomhetens kontroll med lager og varebevegelser
§ 13
Kvartalsvis regnskapsplikt
§ 14
Årlig regnskapsplikt
§ 15
Særskilt rapporteringsplikt for tap og svinn
§ 16
Tilsyn
§ 17
Tilbakekall av tillatelse
§ 18
Gebyr
§ 18a
Overtredelsesgebyr
§ 19
Medbringing av legemidler med innhold av narkotika til eget personlig, medisinsk bruk for reisende
§ 20
Legemidler til førstehjelpsformål
§ 21
Ikrafttredelse
§ 22
Endringer i andre forskrifter